Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 120,478 Raw stories ingested 13,354 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 33s ago
  • FMP Forex News Fetch every 5 min 33s ago
  • CoinGecko News Fetch every 5 min 33s ago
  • FIO Stock News Fetch every 10 min 9m ago
  • Patria Stock News Fetch every 10 min 9m ago
  • Editorial rewrite Rewrite every minute 33s ago
  • Asset sync Assets every 1 hour 19m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-07-13 04:25 28d ago
2026-07-12 20:38 28d ago
3 Dividend Stocks Leading 2026's Rotation Into Value
PEP Pepsi
FMP Stock News
Original source text
The first half of 2026 belonged to artificial intelligence. The second half, so far, has belonged to almost everything else.

In the opening stretch of July, technology has been the market's worst-performing sector. Meanwhile, cash has flowed into the corners investors ignored all year: energy, financials, healthcare, and consumer staples. A soft June jobs report, which showed the economy adding just 57,000 jobs, cooled bets on a Federal Reserve rate hike and gave the rotation a further push.

For income investors, I think a rotation into defensive, dividend-paying stocks is worth a closer look. Three names in particular stand out.

Each is a Dividend King with at least half a century of consecutive annual increases, and each sits at a very different point in this trade. Here's a look at Coca-Cola, Johnson & Johnson, and PepsiCo.

Image source: Getty Images.

1. Coca-Cola: quality, already rewarded Coca-Cola (KO +1.05%) is what the rotation looks like when it works. The beverage giant trades near an all-time high, and the business has earned it. First-quarter organic revenue rose 10% year over year, a strong result for a company this size and this old.

The dividend, of course, is about as secure as dividends get. Coca-Cola has raised its payout for 64 straight years, and the current $2.12 annual dividend uses up only about two-thirds of earnings.

Today's Change

(

1.05

%) $

0.87

Current Price

$

83.50

The one drawback is the price -- at roughly 25 times forward earnings, with a 2.5% yield, Coca-Cola is arguably priced like the defensive stalwart it is. You're buying quality here, but you're not buying it cheap.

2. Johnson & Johnson: the healthcare anchor Johnson & Johnson (JNJ 0.82%) offers a similar kind of durability from a different sector. The healthcare giant just raised its dividend for the 64th consecutive year, matching Coca-Cola for the longest streak of this trio.

Indeed, its first-quarter results gave the increase plenty of cover. Revenue rose about 10% year over year, adjusted earnings per share came to $2.70, and management lifted its full-year outlook to about $11.55 in adjusted earnings per share, helped by strong demand for cancer drug Darzalex and immunology treatment Tremfya.

Today's Change

(

-0.82

%) $

-2.12

Current Price

$

256.98

At about 22 times forward earnings and a 2.1% yield, Johnson & Johnson sits between its two peers here on valuation, though its yield is the lowest of the three. Its dividend consumes less than half of adjusted earnings, so there's ample room for more increases. Investors will get a fresh read soon, too: the company reports second-quarter results this week, on July 15.

3. PepsiCo: the cheap, out-of-favor one If Coca-Cola is the rotation's winner, PepsiCo (PEP 0.35%) is the name it has passed by so far. The snacks and beverages maker trades near a 52-week low.

Its second-quarter report on Thursday explains part of why. Organic revenue grew just 2.4%, in line with the sluggish low-single-digit pace of recent quarters, and volume in its North American beverage business fell 4%.

But there's another side to this. PepsiCo affirmed its full-year outlook, still expects core constant currency earnings per share to grow 4% to 6% for the year, and just raised its dividend for the 54th year running.

Today's Change

(

-0.35

%) $

-0.48

Current Price

$

137.38

After the sell-off, the stock now yields about 4.3% -- comfortably the highest of the three -- at roughly 16 times forward earnings, easily the cheapest. For investors who think the rotation into unloved value has further to run, that's arguably the most direct way to play it in this group.

The better way to play the rotation? So which of these three fits the moment best? It depends on what an investor is after.

The highest quality, for those willing to pay up, is Coca-Cola. The steadiest, and the one giving a fresh read on its business next, on July 15, is Johnson & Johnson. And the best value, for anyone willing to sit through some near-term softness, is PepsiCo.

Personally, in a rotation like this, I lean toward the cheapest, most out-of-favor name, which points to PepsiCo. Its U.S. business isn't at its strongest right now, but a 4.3% yield backed by 54 years of increases pays investors well to be patient.

Of course, none of these is a bargain in absolute terms. And a market that turns back toward growth could leave defensive payers behind just as fast as it found them. But if the rotation into value has staying power, these three sit squarely in its path.
2026-07-13 04:18 28d ago
2026-07-12 23:35 28d ago
ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages First Solar, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FSLR
FSLR First Solar
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of First Solar, Inc. (NASDAQ: FSLR) between February 26, 2025 and February 24, 2026, i1clusive (the "Class Period"), of the important August 24, 2026 lead plaintiff deadline.

SO WHAT: If you purchased First Solar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) defendants had overstated First Solar's capacity to manage the impact of U.S. tariff policy on First Solar's business; (2) defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the First Solar class action, go to https://rosenlegal.com/cases/first-solar-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304899

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 04:16 28d ago
2026-07-12 18:47 28d ago
Best AI Stock to Buy: Micron Stock vs. AMD Stock
MU Micron Technology
FMP Stock News
Original source text
AMD (AMD +2.13%) and Micron (MU 1.05%) have excellent growth prospects over the next several years.

*Stock prices used were the afternoon prices of July 9, 2026. The video was published on July 11, 2026.

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices and Micron Technology. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
2026-07-13 04:15 28d ago
2026-07-12 23:43 28d ago
TSMC to add 2 advanced chip packaging plants in Chiayi, Taiwan minister says
TSM Taiwan Semiconductor
FMP Stock News
Original source text
A general view of the Taiwan Semiconductor Manufacturing Company's (TSMC) fabrication plant in Kaohsiung, Taiwan, June 7, 2025. REUTERS/Ann Wang Purchase Licensing Rights, opens new tab

TAIPEI, July 13 (Reuters) - Taiwan Semiconductor Manufacturing Co (TSMC) (2330.TW), opens new tab will add two advanced chip ​packaging plants in the Chiayi Science Park, ‌the island's science and technology minister said on Sunday.

Located in southern Taiwan, the Chiayi Science ​Park is being developed as one ​of TSMC's major advanced chip-packaging hubs.

Make sense of global markets with the Trading Day newsletter. Sign up here.

TSMC's ⁠first advanced chip packaging plant at the ​Chiayi Science Park has already entered mass ​production and its second plant is expected to begin mass production soon, National Science and Technology ​Council Minister Wu Cheng-wen said at a ​groundbreaking ceremony.

"Today's groundbreaking marks the start of the second ‌phase, ⁠which will include a third and fourth plant," Wu said, adding that the park is expected to generate more than ​300 billion ​Taiwan dollars ($9.35 ⁠billion) in annual production value and create more than 9,000 ​jobs once all four plants are ​up ⁠and running.

TSMC is rapidly expanding its advanced chip-packaging capacity, including its chip-on-wafer-on-substrate technology, as ⁠demand ​from artificial intelligence chip ​designers like Nvidia (NVDA.O), opens new tab continues to outstrip supply.

($1 = 32.0970 Taiwan dollars)

Reporting ​by Wen-Yee Lee; Editing by Thomas Derpinghaus

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-07-13 04:10 28d ago
2026-07-12 23:05 28d ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - RBLX
RBLX Roblox
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive (the "Class Period"), of the important August 7, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Roblox common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Roblox class action, go to https://rosenlegal.com/cases/roblox-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Roblox's organic growth potential; notably, that Roblox would see a significant slowdown in its growth rates as enrollment in the age verification rollout would quickly taper, compounding the resulting slowdown in on-platform communication, resulting in app store rating reductions and a swift reduction in organic growth. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Roblox class action, go to https://rosenlegal.com/cases/roblox-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304895

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 04:07 28d ago
2026-07-12 23:39 28d ago
XPeng: Strong June Deliveries Create Upside
XPEV XPeng
FMP Stock News
Original source text
32.7K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of NIO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-07-13 04:03 28d ago
2026-07-13 04:03 28d ago
Wood: Úvahy o konci americké výjimečnosti jsou notně přehnané Patria Stock News
Original source text
Hledat v komentářích

Investiční doporučení

Výsledky společností - ČR

Výsledky společností - Svět

IPO, M&A

Týdenní přehledy

Detail - články

13.07.2026 6:03

Cathie Wood z Ark Invest prezentovala na Youtube kanále své společnosti řadu názorů na současné dění v ekonomice a na trzích. Domnívá se, že poslední čísla z amerického trhu práce vypadají „divně“, mohla by budit dojem, že ekonomika se nachází v recesi. Wood s takovým pohledem ale nesouhlasí. K tomu dodala, že Fed po vedením Kevina Warshe pravděpodobně bude využívat více dat ze soukromého sektoru namísto vládních statistik. Snižování rozvahy Fedu pak podle ní nebude ničím dramatickým.

Wood dodala, že Warsh se „snad dívá na data ze soukromého sektoru, která ukazují, že inflace je ve skutečnosti mnohem níž, než ukazují vládní čísla.“ Pak mluvila o tom, že růst produktivity by se podle podle ní měl během následujících pěti let zvednout k 5 – 6 %. „Pravděpodobně dříve než později.“ Wood se následně věnovala úvahám o udržitelnosti vládních dluhů: „Nejsme jimi tak znepokojeni,“ řekla k poměru dluhu k HDP, který zelenou křivkou ukazuje následující graf:

Zdroj: Ark Invest

Wood uvedla, že současná vláda „se zaměřuje na snížení deficitů“ a růst celé ekonomiky by měl „výrazně překročit očekávání“. K tomu investorka poukázala na druhou křivku, která popisuje vývoj podílu veřejných dluhů ke kapitalizaci amerického akciového trhu. Kapitalizace podle ní může sloužit jako aproximace celkového bohatství společnosti a křivka pak ukazuje, že dluhy relativně k bohatství mají klesající tendenci.

Za mylná považuje Wood přirovnání se sedmdesátými lety. K nim může podle ní docházet i kvůli tomu, jak po roce 2020 rostly vládní výdaje a peněžní nabídka na úrovni M2. Nicméně růst obojího postupně znatelně ochladl. Mýtem jsou pak podle investorky i úvahy o úpadku dolaru taženém tím, že by zahraniční centrální banky prodávaly americké vládní dluhopisy. Sice existují období, kdy objem těchto dluhopisů v rozvahách centrálních bank klesal, ale celkově k jejich systematickým výprodejům nedochází. A Wood se domnívá, že dolar bude spíše mířit nahoru. Jaké by měly být důvody?

Wood mezi ně řadí hlavně očekávanou deregulaci v USA a některé další kroky současné vlády. K tomu se v USA dosahuje vysoké návratnosti kapitálu a jde o zemi s mimořádně vysokou mírou inovací. To vše by mělo dolar podporovat. A úvahy o konci americké výjimečnosti jsou „notně přehnané“, což mimo jiné ukazují společnosti jako SpaceX, OpenAI a Anthropic. Wood také hovořila o „silných deflačních proudech“, které by měly pramenit z nových technologií a zmíněného růstu produktivity. K tomu dodala, že během průmyslové revoluce byla podle ní výnosová křivka většinou invertována. Výnosy dlouhodobých dluhopisů se tak nacházely pod výnosy krátkodobými.

Tagy: akcie, USA, ARk Invest
Reklama

Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.

Aktuální komentáře

13.07.2026 6:03Wood: Úvahy o konci americké výjimečnosti jsou notně přehnané 12.07.2026 9:22Víkendář: Greenspan předpovídal inflaci 4,5 % a 8% výnosy z desetiletých amerických státních dluhopisů 11.07.2026 9:21Víkendář: Greenspan se evidentně mýlil, akcie nebyly v roce 1996 nijak nadhodnocené 10.07.2026 17:39Nemělo by se nyní více mluvit o nesprávném monetárním kurzu? 16:08Bylo by nebezpečné vědět, proč centrální banky jednají tak, jak jednají? 14:10Analytici otáčejí. Očekávání zisků evropských firem rostou nejrychleji za dva roky   12:22Perly týdne: Červená karta pro Američany a klesající dynamika akcií malých firem 11:02Volkswagen spouští jednu z největších proměn ve své historii. Omezí výrobu i nabídku modelů 10:51Techy korigují včerejšek, ale trhy mezitím podporuje obnovení jednání s Íránem   10:41ExxonMobil může těžit z návratu geopolitických rizik. Má prostor pro růst akcií   9:24O easyJet se rozhořel boj. Apollo nabídlo víc než konkurence a získalo podporu vedení 9:01Rozbřesk: Polská centrální banka drží sazby, Glapiński se nebrání podzimnímu snížení 8:54Babiš otevřel debatu o IPO Letiště Praha, ČNB varuje před návratem inflace a optimismus kolem AI se vrací   6:04Nejvýnosnější akciový trh roku? Jižní Koreu sesadila Nigérie 09.07.2026 17:25Pracují nyní trhy pro Fed nebo proti němu? A jak dopadnou testy nových monetární myšlenek? 16:06Existují skutečně důvody pro zvedání sazeb? 14:14SK Hynix míří na Nasdaq. O jeden z největších burzovních debutů v historii je obrovský zájem   14:01Nápojový kolos PepsiCo zvýšil čtvrtletní zisk, u růstu tržeb překonal odhady 13:58Výsledková sezóna v USA: Kalendář pro 2. čtvrtletí 2026 13:56Výsledková sezóna v Evropě: Kalendář pro 2. čtvrtletí 2026
Reklama

Související komentáře

Nejčtenější zprávy dne

Nejčtenější zprávy týdne

Nejdiskutovanější zprávy týdne

Kalendář událostí

Nebyla nalezena žádná data
2026-07-13 03:55 28d ago
2026-07-12 22:43 28d ago
Rocket Lab Shakes Up Satellite Communications
RKLB Rocket Lab USA
FMP Stock News
Original source text
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Jon Quast, Matt Frankel, and Rachel Warren discuss:

Comcast spins off NBCUniversal.Whether NBCUniversal is an attractive takeover target.Rocket Lab’s $8 billion acquisition.Selling stocks you love to buy stocks you love more.To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.

A full transcript is below.

This podcast was recorded on June 29, 2026.

Jon Quast: Breakups, buyouts and selling stocks, all this and more on today's Motley Fool Hidden Gems Investing. Welcome to Motley Fool Hidden Gems Investing. I'm Jon Quast, and I'm joined today by foolish contributors Matt Frankel and Rachel Warren. Today, we're talking about a shake-up in outer space, as well as taking a listener question about selling stocks.

But first, we’ve got to talk about Comcast because it's breaking up. Now, in January, it already spun off its TV channels and some Internet properties, CNBC, golf, Rotten Tomatoes. It spun those off into Versant Media Group, Ticker symbol VSNT, but now Comcast is coming back here for Round 2, announcing it will spin off NBCUniversal, which contains a lot more than just the channel NBC. Now, as I zoom out here, Comcast stock down about 30% over the past year prior to this announcement, and one announcement here, sending the stock up 20% pre-market, up about 10% now. The market is giving it roughly $10-15 billion more in market cap just for announcing this move, and that is an absolutely massive swing. Were investors really punishing this stock so much because it was a conglomerate?

Matt Frankel: Well, yes, the new company will include all the entertainment and broadcasting assets, including the NBC Network, as you mentioned, that's still part of it, Telemundo, the Peacock service. It also includes the Universal Film and TV studios, the Universal theme parks, and the Sky European business. The remaining Comcast will really just be the broadband and wireless services, which is a pretty big business. It has 65 million subscribers. There are a few reasons why investors might be cheering the news. As you correctly said, the stock was down about 30% over the past year, going into this with the so-called conglomerate discount hurting it, but not for the reasons that you might think. NBC Universal could be a lot more valuable as an entertainment content play, especially when it comes to being an acquisition target, and that's really the environment we're in right now. Remember when Warner Brothers Discovery planned to spin off its cable, TV, and studios business announced that, and then it became the trigger for a bidding war between Netflix, Paramount, which eventually got it, and a few others.

Today's surge represents investors pricing in a similar outcome here. It remains to be seen if it actually happens, but this could really be the next big consolidation play for the industry. Amazon and Apple are two examples of companies that could be interested just to name a couple of speculative names off the top of my head, but there are definitely others.

Rachel Warren: The primary driver of any shareholder value moving forward is the creation of two pure play entities that can be valued independently on their own merits. The remaining Comcast could potentially transform into a leaner, more profitable telecom giant focused on broadband infrastructure and wireless connectivity. That's the bullish thesis there. Obviously, without the financial drag of funding expensive streaming content, and then you can see how this new Comcast could redirect free cash flow directly towards share buybacks, dividend hikes, paying down corporate debt. I'll note, this is a tax-free spin-off, so current Comcast shareholders will receive shares of the new NBC Universal company without triggering an immediate tax liability. Comcast, for their part, they're keeping a 19.9% massive stake in the new media company and they intend to monetize that over the first year. Still a notable presence where that's concerned.

Jon Quast: Matt, I want to circle back to you here because it does sound like you're saying that a bigger player might want to acquire NBC Universal once it is spun out, and you mentioned Amazon and Apple specifically. Are you being serious here, or are you just daydreaming?

Matt Frankel: Well, I think that's fair to say. There are a lot of these content providers who are leaning into live content. They would love to expand the intellectual property and their streaming services and so on and so on. Now, there are some companies that would be unable to acquire NBC Universal, most likely, Disney is an example. There's a lot of complementary parts of the business, but they would run into a theme park monopoly problem, I think. They might as well just buy Orlando if that was the case. But for a company like Amazon, it would make a lot of sense. Think of what they would be getting. They'd be getting the rights to things like NBC's Olympic coverage, NFL Sunday night football. They're clearly pushing into live content, and the fact that they already own the MGM Studios, it could be a nice, smart addition to compete with other big streaming providers. Apple has been lagging in the content wars and has the cash to acquire something like this, rather than focusing too much of their attention on building it from scratch.

Jon Quast: Matt's giving us a bull case here, wherein NBC Universal is worth more on the public auction block than it was inside of Comcast. But let’s say that Amazon never does make a bid, and this company here, NBC Universal, just has to stand alone and compete. Does this company actually have what it takes to survive the streaming wars independently, or is it going to shake up the industry in some way, Rachel?

Rachel Warren: I don't see this as a player that shakes up the industry on its own. If you look at it on a standalone operational basis, NBC Universal faces the same brutal headwinds as any traditional media giant, from cord-cutting to the expense of streaming wars. But Wall Street's not really bidding the stock up because they expect NBC Universal to suddenly grow its way out of the media crisis. I think the excitement is the idea that this newly independent NBC Universal could be an incredibly attractive acquisition asset overnight. You think about how by stripping away Comcast's massive broadband infrastructure, the Roberts family has essentially turned an unbuyable telecom giant into a neatly packaged comprehensive acquisition target. I think that’s where the mindset is, cash-rich tech giants or media platforms that want a world-class theatrical engine like Universal Pictures, other iconic IP, global theme parks, and so on. They could bid directly on this media powerhouse without having to run the legacy telecom side. We will see. These are all predictions that we're baking, but I would not be surprised if there are quite a few tech giants or media platforms that are looking at the landscape with a great deal of curiosity and acquisitive interest than there were a few days ago.

Jon Quast: It looks like NBC Universal is either going to need to learn to compete on its own or it may be an attractive takeover target. Either way, we'll be watching, but speaking of attractive takeover targets, we've got a big one to talk about in the space race after the break. You're listening to Motley Fool Hidden Gems Investing.

ADVERTISEMENT: Head to the beach in Abercrombie's latest summer drop. New 100% linen shirts are perfect for breezy days by the coast. They're easy to layer and go well with our new sea-faded shorts. For days spent on the water, pair the ANF resort shirt with your favorite swimsuit. Outfit your summer with Abercrombie, in the app, online, and in stores.

Jon Quast: Welcome back to Motley Fool Hidden Gems Investing. Let's move here from the spin-offs to acquisitions. Rocket Lab announcing this morning it's acquiring Iridium for $8 billion. This was a surprising move for me this morning. Iridium is a satellite communications company, not unlike StarLink from SpaceX. I think that investors tend to view Rocket Lab as SpaceX's little brother. The company is prone to doing big acquisitions, but this is a different level of big acquisition. This is not baby brother-level acquisition at $8 billion. Does this move signal something more aggressive to become a true Pepsi to SpaceX's Coke, Rachel?

Rachel Warren: Well, in the modern space economy, a launcher can no longer survive strictly on the low margins of launching rocket ships for third parties. To become a true peer to the likes of SpaceX, a company needs to own and operate the really lucrative satellite networks those rockets carry into orbit. By taking control of Iridium's active low Earth orbit fleet, it's globally coordinated L Band spectrum, very robust base of active subscribers, Rocket Lab could bypass years of capital drag, and this can transform that business from more of a launch utility into an end-to-end global satellite service entity. I think that is probably the vision that management has. It can also give Rocket Lab highly profitable recurring subscription cash flow it needs to fuel that long term growth. This is a very capital-intensive business, and as well to aggressively fund its upcoming medium lift Neutron rocket.

Now, moving forward, maybe there's this idea that Rocket Lab could achieve complete vertical integration by deploying and replenishing Iridium's future constellations using its own launch systems, and that way, they could capture those manufacturing and launch margins internally. SpaceX's Starlink focuses on high-bandwidth direct-to-consumer broadband Internet. Iridium corners the gold standard of safety-critical global voice data and Internet of Things applications. Not necessarily fighting head-to-head for residential Internet users. But I think Rocket Lab is trying to gain a foothold in those industrial maritime and defense infrastructure applications, and this can help it very much establish a resilient counterweight to SpaceX's orbital monopoly.

Jon Quast: Matt, what is Rocket Lab exactly getting here?

Matt Frankel: They're buying a few things here, and Rachel mentioned some of these. They have a network of 66 satellites in operation right now, about 2.5 million subscribers between them. It's a network really importantly that would cost years to build and billions of dollars, and it's really the time commitment that Rocket Lab doesn't need. There's a race to get there when it comes to controlling the space economy and waiting 10 years to build out a satellite network is not attractive thing. They're also getting 9 MHz of spectrum, which is a narrower bandwidth than SpaceX has for Starlink. Starlink is broadband, and this is narrowband. But it is a very important asset, and they're also buying profitability.

Rachel mentioned that Iridium is a profitable business. But that's really important here because Rocket Lab, I think their net loss was about $180 million last year. This gets them $100 million of profitability back, so it creates a better path to profitability. But I don't really see this as Rocket Lab trying to become the next SpaceX. Maybe I have an unpopular opinion on that. Iridium's network, it's more about reliable connectivity as opposed to broadband speeds. Think satellite phones, the safety type things, things that you have to have, say if you're in the middle of nowhere. It's not a market that SpaceX is really targeting. There's some competition here, like the direct to sell connectivity that StarLink and Rocket Lab Iridium are both trying to build out that essentially use the satellites as a fallback for when you don't have self service. But that's not the primary focus of what Iridium does, and I see this as being a different business competing in the global bandwidth spectrum, I guess.

Jon Quast: Well, I can't help but think that maybe Rocket Lab is overpaying here because at an $8 billion price tag, that's about nine times sales for Iridium and Iridium is growing at just a single digit rate. I don't know. It just seems like a high price to pay, Rachel.

Rachel Warren: A 9X top-line multiple is high. I won't argue with you there. It also translates this deal to roughly 16X EBITA multiple based on their $495 million in EBITA. But I will say, Iridium, they have got 57% operational EBITA margins, very predictable recurring cash flows that have been for a long time anchored by resilient government contracts. This does provide Rocket Lab with something of a financial cushion to fund that ongoing development of the Neutron rocket without constantly diluting shareholders, as well as hopefully minimizing some of the capital drag as they're building out their low Earth orbit network. Also note, Rocket Lab secured a $3.6 billion bridge loan commitments from Deutsche Bank and Wells Fargo to back this $54 a share cash and stock deal. That's a little bit of added context for the parameters of this acquisition.

Jon Quast: Well, regardless of the price tag, I think that all of us agree that this is a massive move for Rocket Lab. We'll find out within a year or two whether it was visionary or reckless. But after the break, we're going to dip into the mailbag. You're listening to Motley Fool Hidden Gems Investing.

ADVERTISMENT: HBO Max is now on Prime Video. So many great stories one destination. Journey back to Westeros with the third season of House of the Dragon. Draw your sword. Don't miss the intense new season of Euphoria. What we didn't realize was how far we were willing to go. Follow Dr. Robbie through a gripping real time shift in the pit. It begins. You also get access to so many timeless shows from succession to the last of us. Subscription required T&Cs apply, 18+. HBO Max is used under license.

ADVERTISMENT: So you are a professional plumber, yes. But do you have professional website? Not so much. Try AIONOS. It's turbocharged AI Power works super fast to bring your Wordpress website to life and deliver top of the draw results every time, and it's clever auto updates do all the hard work of maintaining your site so you can get on with maintaining your business. How's that? Nice. Try AIONOS, your digital partner at aionos.co.uk.

Jon Quast: Welcome back to Motley Fool Hidden Gems Investing. One quick note, we want to make you a part of the conversation. If you have a stock or investing question for Matt, Rachel, or myself, anyone on the show, really, you can email us at [email protected], and we'll take that question if it is a good one, if it is short, and if it is Foolish, send those in to [email protected]. We are indeed taking a question from the mailbag here today.

The question reads like this. I've been following foolish investment principles for about eight years. My only regret is that I didn't find Motley Fool sooner. I am fully invested and like all my stocks. Here is the question. How do I pick which investments to sell in order to invest in new Foolish recommended stocks, and when I retire in a few years, how do I pick stocks to sell for income? Not signed D Money. I like that name. I wanted to point out here before I throw this question to Matt and Rachel. I want to point out one of the things I love about The Motley Fool Investment philosophy is that it encourages investing new money regularly into the stock market. I know that that's not always a luxury that listeners have or investors have, but one of the benefits of that, especially in this context where D Money says, I like all my stocks. Sometimes that's the case. Sometimes you're invested in things that you do like and you don't want to sell.

But there are other things you'd like to buy as well. That's the beauty of investing new money regularly, if that's an option. I don't have to make that choice between, do I sell this one or keep this one? I'm just continuing to invest new money for new ideas, but that caveat out of the way with The Motley Fool Investment philosophy, not advice, but just general philosophy that we're giving there. I'm going to throw this to Matt first. Matt, what do you think about this question from D Money?

Matt Frankel: There's two separate parts there, there's how do I free up capital to buy new stocks that I'm interested in, and how do I free up capital when I'm retired? I'm not going to buy other stocks, but I just need the money to live on. Two different questions there. The first one is a difficult question, mainly because the listener has done a lot right. Being fully invested in a portfolio of stocks that you truly believe in is like the ongoing goal of long-term investing. There are a few ways you can think about it. Even though you like all your stocks, ask yourself the question about each one of these. Well, two questions. No. 1, would I buy the stock today at the current price if I didn't already own it? No. 2, do I see myself continuing to build out this position in the future? Those are the two questions I ask to determine my conviction level in all the stocks I own. From there, you can make a list of, say, your 10 highest conviction stocks. Those are off the table to sell, but you can also identify your lower conviction positions, which can become sell candidates, either in full or partially, when you want to act on a particular recommendation. There are certainly other things to consider there, such as the tax consequences if you're selling a stock that you own that has gone up in value a lot.

But as far as selling stocks for income in retirement, here's my general framework, and this is coming from someone who's probably two decades away from retirement, but I'm a certified financial planner, and I've dealt with this with clients before. First, aim to get to retirement with 2-3 years of expenses in either cash or similar assets, like money market funds, high yield savings accounts, short-term treasuries, things to that effect, that eliminates the need to sell any stocks immediately if you don't want to, which that could be worth its weight in gold if you retire and then the market crashes. You don't have to sell your stocks into a bad market. Then you have two buckets from your portfolio. You have your more conservative stocks. These are dividend stocks like your compounders. Berkshire Hathaway is one I would put in this basket. Those make the best choices to gradually tap into for cash when needed. There are stocks that are generally lower volatility. You don't have to really worry about the long-term holding period. Then you can use that other bucket of stocks, which are your long-term growth holdings for that targeted five-plus-year hold, which is really a cornerstone of foolish investing. That's how I think of gradually drawing down your portfolio in retirement, but just my opinion.

Rachel Warren: Well, to our listener, huge congratulations on building a portfolio of businesses that you love. We've talked about this. Ideally, we're buying fresh recommendations for a portfolio with new cash so that we can leave our winners compounding uninterrupted. But this isn't always realistic. Sometimes, where our investing capital is maxed out, or obviously, if you're transitioning into retirement, you have to work with the portfolio you have. I'll talk a little bit about what my mindset has been, someone that is still a bit far off for retire, so to speak, but very much is constantly evaluating my portfolio and looking at ways to grow my winners and to trim those that I don't want to keep in my portfolio anymore.

For me, looking at my biggest winners, if I think that a company has grown so much that say, now it makes up 15-20% of my total portfolio composition. In my view, that really exposes one to massive single stock risk. Sometimes shaving off just a tiny sliver of that outsized position can be a good way to fund new diversified business. That can be a really healthy way to manage your risk without abandoning the company and the position entirely. I think as well, what I'm looking at whether I want to trim a position in my portfolio, I also evaluate the underlying reasons that I bought the stock. Is the management team still executing? Is the competitive moat what it was or has it degraded? If a business has perhaps stalled, if some of those growth tail winds have turned into headwinds, that for me is usually a clear candid to trim, even if I still really like the business, and that can also yield some fresh capital that I can put back into the market and into growing my portfolio.

Jon Quast: I couldn't agree more with that. To know when to sell, you first have to know why you bought and then evaluate off of that. But thank you to Matt and Rachel. That's all the time we have for today.

As always, people on the program may have interest in the stocks they talk about, and The Motley Fool may have formal recommendations for or against, so don't buy or sell stocks based solely on what you hear. All personal finance content follows Motley Fool editorial standards and is not approved by advertisers. Advertisements are sponsored content and provided for informational purposes only. To see our full advertising disclosure, please check out our show notes. Thanks to our producer, Dan Boyd, and the rest of The Motley Fool team. For Matt, Rachel, and myself, thank you so much for listening to our show today, and we'll see you again in the next episode.
2026-07-13 03:34 28d ago
2026-07-12 22:09 28d ago
Alliance Resource Partners: More Than Coal As AI Fuels The Pivot
ARLP Alliance Resource Partners
FMP Stock News
Original source text
Alliance Resource Partners remains a Buy as it leverages strong coal cash flows to fund a strategic pivot into oil, gas, and future-facing royalties. Despite a Q1 DCF drop to $77.79M and lower coal prices, ARLP maintains robust distribution coverage and 95% of 2026 coal sales volumes committed and priced. The company's $206M oil and gas royalty acquisition diversifies its portfolio further, positioning it for long-term performance as coal cycles potentially wane and energy demand shifts.
2026-07-13 03:09 28d ago
2026-07-12 22:43 28d ago
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Verra Mobility Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - VRRM
VRRM Verra Mobility
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Verra Mobility Corporation (NASDAQ: VRRM) between February 24, 2026 and May 26, 2026, inclusive (the "Class Period"), of the important August 4, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Verra common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Verra class action, go to https://rosenlegal.com/cases/verra-mobility-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Verra's relationship with Avis Budget Group ("Avis"), and in particular obtaining a contract extension with Avis. Further, Verra minimized concerns that major rent-a-cars could replace Verra with in-house solutions or outsourced alternatives. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Verra class action, go to https://rosenlegal.com/cases/verra-mobility-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304896

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 03:08 28d ago
2026-07-12 12:00 28d ago
Bronstein, Gewirtz & Grossman LLC Urges Calix, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
CALX Calix
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Calix, Inc. (NYSE: CALX) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Calix securities between January 28, 2026 and April 21, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CALX.

Calix Case Details

The Complaint alleges that throughout the Class Period, defendants failed to disclose to investors:

the Company's first quarter margins had significantly benefited from advanced purchasing of memory components; that the Company's advanced supply of memory components was dwindling; that, as a result, the Company was experiencing negative margin pressure as it was forced to purchase memory components at rising market prices; and that, as a result of the foregoing, Defendants' positive statements about the Company's margins, business, operations, and prospects were materially misleading and/or lacked a reasonable basis.What's Next for Calix Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CALX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Calix you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Calix Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Calix Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299462

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 03:03 28d ago
2026-07-12 20:50 28d ago
Duolingo Is Still Impressive, But No Longer Cheap (Rating Downgrade)
DUOL Duolingo
FMP Stock News
Original source text
Duolingo has delivered strong top- and bottom-line growth, with shares up 39.1% since the March upgrade to 'Buy'. User engagement and monetization are accelerating, with DAUs up 21.2% and paid subscribers up 21.4% year over year. AI-driven feature expansion and content automation are driving platform stickiness and operational leverage, supporting long-term growth.
2026-07-13 02:53 28d ago
2026-07-12 22:04 28d ago
Better Senior Housing REIT: Sabra Health Care or Welltower?
SBRA Sabra Healthcare REIT
FMP Stock News
Original source text
Welltower grew revenue and normalized funds from operations by double-digit percentages. Sabra has a dividend that yields above 6%.
2026-07-13 02:52 28d ago
2026-07-12 20:29 28d ago
Manhattan Associates, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. - MANH
MANH Manhattan Associates
FMP Stock News
Original source text
, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).

If you currently own shares of Manhattan Associates stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=35966 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected].

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.
2026-07-13 02:48 28d ago
2026-07-12 18:34 28d ago
KKR Leads A$400 Million Financing Solution for Ampol
KKR KKR & Co LP
FMP Stock News
Original source text
SYDNEY--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced its cornerstone investment in a A$400 million (US$275 million) financing solution (the "Financing") for Ampol Limited (ASX: ALD) ("Ampol"), anchored by KKR's private credit and insurance platforms. The investment will support Ampol’s refinancing initiatives and other general corporate purposes, in line with its Capital Allocation Framework.

Listed on the ASX, Ampol operates an integrated fuel supply and marketing value chain in Australia that encompasses the Lytton refinery in Queensland, an extensive national network of terminals and pipelines, and a convenience retail footprint of approximately 1,700 sites. Ampol also maintains a significant presence in New Zealand with approximately 500 retail sites and has international operations via its trading and shipping capabilities based in Singapore and the USA.

KKR’s Asia Pacific Credit platform seeks to provide, among other private credit strategies, bespoke solutions to high-quality companies, entrepreneurs and sponsors that harness the strength of KKR’s private markets investment capabilities and its expertise as one of the largest alternative credit managers globally.

Diane Raposio, Partner and Head of Asia Credit and Markets, KKR, said, “We are focused on providing flexible capital to high-quality companies as they pursue their strategic objectives. Ampol is an established, strong investment-grade business with a long operating history and a sophisticated approach to capital management. We are pleased to partner with Ampol on this financing, building on KKR's track record in the ANZ region and across Asia Pacific.”

Greg Barnes, Group Chief Financial Officer, Ampol, said, “The transaction is another example of our proactive approach to funding and capital management. We are delighted with the significant support received from KKR on this occasion, and our collaboration with Temasek-backed Clifford Capital in arranging the transaction with our advisers. We have a meaningful presence in Singapore and value the partnership with KKR and Clifford Capital.”

KKR’s investment was supported by Clifford Capital, a Temasek-backed and Singapore-headquartered global infrastructure credit platform, reflecting the firm's capability in delivering tailored capital solutions and connecting institutional investors with leading corporates across the Asia Pacific region.

Vidyasagar Pulavarti, Chief Investment Officer, Asset Management, Clifford Capital, said, “Private investment grade credit continues to present compelling opportunities for institutional investors seeking resilient, long-term returns. We are delighted to collaborate with KKR, Ampol and Barrenjoey on this transaction, which underscores Clifford Capital Asset Management’s role as a trusted partner in accessing, structuring and delivering high-quality private credit assets, underpinned by rigorous investment discipline and robust Investment Committee oversight through our Private Investment Grade strategy.”

KKR is making this investment from its Asia Pacific Credit strategy and insurance platform. In Australia, KKR has provided bespoke solutions to Family Doctor, a leading group of general practitioner clinics, DBG Health, a leading pharmaceutical company, and Lendi, a leading fintech, and financings to companies and sponsors across a range of industries and private credit strategies. Since 2019, KKR has committed more than US$9.1 billion across 63 credit investments under its Asia Pacific Credit strategy, accounting for a total transaction volume of more than US$28.4 billion.

Disclaimer

This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for the Financing in the United States or any other jurisdiction where to do so would be unlawful. The Company has not registered, and does not intend to register, any portion of the Financing in the United States or any other jurisdiction and does not intend to conduct a public offering of securities in any of these jurisdictions.

In particular, the Financing has not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state or other jurisdiction of the United States. The Financing may not be offered or sold, directly or indirectly, in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws. The offering is being made only to (a) persons outside of the United States or (b) "qualified institutional buyers" ("QIBs") within the meaning of Rule 144A under the Securities Act ("Rule 144A"). Prospective purchasers are hereby notified that the sellers or issuer of the Financing may be relying on the exemption from registration requirements of the Securities Act provided by Rule 144A or another available exemption from registration.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.
2026-07-13 02:05 28d ago
2026-07-12 19:56 28d ago
Meta Stock: A Cash-Gushing Ad Giant With a Powerful Moat but Limited Diversification
FB Meta Platforms
FMP Stock News
Original source text
Discover why Meta Platforms (META +6.16%) remains a cash-generative advertising powerhouse, yet still leans heavily on its vast social network and user data for growth. Watch the video below to see how this concentration shapes Meta's long-term investment profile.

*This video was published on Jul. 2, 2026.

Lou Whiteman has no position in any of the stocks mentioned. Matt Frankel, CFP® has no position in any of the stocks mentioned. Toby Bordelon has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet and Meta Platforms. The Motley Fool has a disclosure policy.
2026-07-13 01:53 28d ago
2026-07-12 21:02 28d ago
Zeta Global Eyes AI Infrastructure Shift as Palantir Integration Nears
PLTR Palantir Technologies
FMP Stock News
Original source text
Palantir’s Valuation Problem Just Met 2 New Growth CatalystsZeta Global NYSE: ZETA executives said the company is moving beyond its core marketing technology positioning and toward what they described as an AI infrastructure and business intelligence platform, supported by recently announced partnerships with Palantir, OpenAI and Snowflake.

Speaking during a webcast discussion hosted by Ron Josey, Co-Founder, Chairman and CEO David Steinberg and CFO Christopher Greiner did not provide an update on second-quarter trends, with Josey noting that Zeta was entering its quiet period. The discussion focused instead on Zeta’s product strategy, partnerships and longer-term positioning.

Get Zeta Global alerts:

Palantir Integration Expected Within Weeks As Digital Ad Spend Hits a High, These Firms Could Reap RewardsSteinberg said Zeta expects to complete the first phase of its Palantir integration within “30 to 40 days,” with existing Data Cloud clients moving onto Palantir’s Foundry platform. He said the migration should be seamless for clients and is expected to improve the speed of intelligence within Zeta’s platform.

“All our existing clients that are using the Data Cloud will move over to Foundry in the next 30 to 40 days,” Steinberg said. He added that Zeta expects to have “at least one joint launched enterprise client” from Palantir’s side during the current quarter.

The Next Market Leaders? 5 Growth Stocks to Watch in 2026Steinberg described Foundry as a new foundation for Zeta’s broader platform ambitions, saying it would allow the company to combine Zeta’s Data Cloud with clients’ business data for real-time decisioning. He said the company is formally adding a fourth use case, called Zeta Business Intelligence, or ZBI, alongside customer acquisition, customer retention and customer monetization.

According to Steinberg, ZBI is aimed at a U.S. business intelligence market that he said IBIS estimates at $35 billion annually. He said current business intelligence tools often rely on historical data, while Zeta aims to use its Data Cloud and client data to help forecast future business outcomes.

Athena Positioned as Interface for AI Workflows Zeta’s Athena product, which Steinberg said became generally available earlier this year, was presented as a key interface for the company’s platform. Steinberg said Athena is intended to reduce friction between users and enterprise software by allowing customers to ask questions conversationally, either by voice or through a chat box.

He said Athena can help clients access more of Zeta’s feature set and data sets without manually navigating multiple screens. As an example, Steinberg said a client could ask Athena how to create incremental customers while lowering marketing costs, and Athena would generate recommendations within the platform.

Steinberg said some clients that have adopted Athena are seeing returns on marketing spend of more than 1,400%, while also emphasizing that not all clients are at that level. He said Zeta’s broader return on marketing spend was measured at more than 600% in an independent Forrester survey.

Greiner said customers using Zoe, an earlier generation of Zeta’s automation and voice capabilities, spent “between 200% and 350% more” on the platform when they leveraged automation.

OpenAI Partnership Expands Across Products and Internal Tools Steinberg said Zeta’s relationship with OpenAI began with the company seeking a voice engine for Athena. He said Zeta uses OpenAI’s voice capabilities while continuing to run its Data Cloud on Zeta’s own proprietary models, which he said the company has been developing since 2017.

“We never use any large language model to see any data in our Data Cloud,” Steinberg said. He described Zeta’s future in business AI as focused heavily on inference-based artificial intelligence rather than relying only on large language models.

Steinberg also said Zeta recently expanded its OpenAI relationship by making ChatGPT available to all global employees, replacing Microsoft Copilot internally. He said Zeta also works with other AI models and tools, including Claude, Gemini and Cursor.

The OpenAI relationship also extends to advertising, according to Steinberg. He said OpenAI awarded Zeta “a meaningful component” of its marketing serving business after initially working with Zeta as a technology partner.

Gap Win Cited as Evidence of Platform Shift Steinberg pointed to Gap as a major recent customer win, saying Zeta displaced four vendors, including Salesforce and Braze, and became Gap’s system of record for a contract focused on CRM and monetization.

He said Zeta had bid on Gap requests for proposal at least twice in prior years and finished second, but that Athena helped change the outcome this time. “I am 100% confident that Athena was the reason we went very quickly from this very long RFP process to them saying, ‘Okay, send us pricing,’” Steinberg said.

Steinberg said Zeta is working with Publicis Sapient on the Gap engagement and has built a forward-deployed engineering team working with Gap, Palantir and OpenAI personnel.

Executives Discuss Revenue Model and Long-Term Targets Greiner said Zeta’s revenue mix remains partly recurring software and partly utilization-based. He said recurring software represents about 60% of revenue, while utilization represents about 40%.

Greiner said the model remains predictable because more than 90% of revenue comes from customers that have been with Zeta for more than one year, and nearly three-quarters comes from customers that have been with the company for more than three years. He said recurring revenue has grown 36% over a multi-year period, while utilization revenue has grown 25%.

Steinberg said Zeta has reported 19 quarters as a public company and has “beat” and raised guidance 19 times. He also said the Palantir agreement’s expenses have already been budgeted for this year and future years, with spending shifted from other vendors to Palantir. He said the partnership should be additive to operating margins in future years.

Greiner said the Palantir partnership increases confidence in Zeta’s long-term model, including the company’s ability to reach its targets early. He said the company is ahead on the operating metrics it has published for its 2028 targets, including scaled customer growth, customer spend growth and net revenue retention.

Steinberg said Zeta’s largest competitive advantage is its Data Cloud, citing 535 million consented individuals, an average of 5,000 to 7,000 data elements per person and first-party relationships with more than five million publishers. He said the company’s goal is to embed more deeply into enterprise technology stacks and be viewed as mission-critical infrastructure rather than a software expense.

Zeta also previewed its Zeta Live event, scheduled for Oct. 8 in New York City. Steinberg said the company plans additional product roadmap updates at the event and reiterated that Zeta’s goal is to turn Athena into “a full operating system” for clients’ businesses.

About Zeta Global NYSE: ZETAZeta Global, founded in 2007 and headquartered in New York City, is a leading data-driven marketing technology company. The firm's mission centers on helping brands acquire, grow and retain customers through a unified customer lifecycle management platform. Over the years, Zeta Global has built a reputation for leveraging big data and predictive analytics to power digital marketing programs across multiple channels.

At the core of Zeta's offering is the Zeta Marketing Platform, which combines identity resolution, audience insights and real-time engagement capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Zeta Global Right Now?Before you consider Zeta Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zeta Global wasn't on the list.

While Zeta Global currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
2026-07-13 01:52 28d ago
2026-07-12 21:08 28d ago
Is a Deal With Ford and a $100 Billion Backlog Enough to Get Micron Stock Back Over $1,200?
MU Micron Technology
FMP Stock News
Original source text
After hitting a 52-week high of $1,255 on June 25, the Micron Technology (MU 1.05%) stock price has since retreated below $1,000. There's a likely mix of factors that have led to that decline and that are keeping the stock price from rebounding, ranging from potential profit-taking to a chip stock sell-off to increased competition from SK Hynix's listing on the Nasdaq.

In the background, however, there was a July 6 announcement from Micron that seemed to get buried.

Image source: The Motley Fool.

Micron locks in Ford On July 6, Micron Technology announced that it had entered into a long-term agreement, which it called a strategic customer agreement (SCA), with Ford to help strengthen the automaker's vehicle production. "Producing the high-volume vehicles of the future in the U.S. will require a resilient supply chain," Ford CEO Jim Farley said in the announcement.

Micron didn't offer specifics about the deal's value. But it did say the SCA was part of a collective 16 it discussed in its 2026 third-quarter earnings call.

Today's Change

(

-1.05

%) $

-10.39

Current Price

$

981.25

In that call, Micron shared that it had strategic agreements, ranging from deals with automakers to hyperscalers, spanning three to five years. From those 16 agreements, it has $22 billion in deposits and financial commitments. In total, those agreements are expected to generate over $100 billion in revenue, a figure that may be conservative.

The news alone didn't push Micron back to its 52-week high of $1,255. But working to lock in future revenue over the years ahead can help it shed its cyclical reputation, building a stronger case for Micron as a long-term investment.

Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Micron Technology. The Motley Fool recommends Nasdaq. The Motley Fool has a disclosure policy.
2026-07-13 01:46 28d ago
2026-07-12 20:30 28d ago
Why Strategy Stock Collapsed In The First Half of 2026
MSTR Strategy
FMP Stock News
Original source text
Shares of Strategy (MSTR +0.80%) -- formerly MicroStrategy -- have fallen by 42.8% in the first half of 2026, according to data from S&P Global Market Intelligence. The software provider that pivoted to becoming an aggressive Bitcoin treasury company has seen its strategy (no pun intended) begin to unravel with the price of Bitcoin down severely over the last twelve months.

To fund interest payments, Strategy has begun selling some of its Bitcoin, which has spooked the market. Here's why the stock was falling in 2026, and whether now could be a good time to buy the dip on this fallen giant.

Today's Change

(

0.80

%) $

0.75

Current Price

$

94.64

Following the price of Bitcoin When Bitcoin was over $100,000 a coin, Strategy actually achieved a market cap of over $100 billion, and had a nice premium to the underlying value of the assets on its balance sheet. Using this premium, Strategy was able to sell shares of its stock to buy more Bitcoin, thereby theoretically creating value per share due to the valuation premium.

With enthusiasm for cryptocurrencies beginning to wane and the price of Bitcoin falling, Strategy's stock premium has fully collapsed. Its share price is now down 80% from its highs, driven by this convergence with the underlying value of Bitcoin on its balance sheet, as well as the price of Bitcoin falling in the last year.

Now, with interest payments piling up on preferred stock and on outstanding debt used to buy Bitcoin, Strategy has been forced to liquidate some of its Bitcoin position to fulfill its ongoing obligations. As of this writing, it has been only 3,500 Bitcoin sold, which is a small amount relative to Strategy's balance sheet, but the signal to markets was nonetheless fear-inducing.

Image source: Getty Images.

Should you buy the dip? Strategy's old mandate was to keep buying Bitcoin through various forms of fundraising methods, be it debt, preferred stock, or issuing new shares. This party continued as the price of Bitcoin soared. Now, on the other side of the popping of a cryptocurrency bubble, a hangover of this business strategy is starting to rear its ugly head.

The stated value of its Bitcoin assets is over $50 billion at the current Bitcoin price of $64,000, but Strategy has $22.2 billion in liabilities, including a massive amount of preferred stock with double-digit annual interest payments, resulting in over $1 billion in funding requirements each year. With no underlying business to fund these interest payments, Strategy will be forced to sell even more Bitcoin, potentially leading to the dissolution of this entire business model unless the price of Bitcoin rises.

This makes the stock one investors should not buy the dip on right now.
2026-07-13 01:44 28d ago
2026-07-12 21:31 28d ago
BDC Dividends Face a Reckoning As Fed Rate Cuts Squeeze Earnings
ARCC Ares Capital
FMP Stock News
Original source text
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© Panchenko Vladimir / Shutterstock.com

The VanEck BDC Income ETF (NYSEARCA:BIZD) just delivered a jolt to income investors: its July distribution came in at $0.24 per share, roughly half the $0.48 paid in April. BIZD passes through the dividends of the business development companies it owns, so when the underlying BDCs strain, BIZD’s payout wobbles. With the fund down 14% over the past year and BDCs facing base-rate cuts and spread compression, the question is whether this distribution is a one-off dip or the start of something worse.

How BIZD Actually Pays You BIZD tracks the MVIS US Business Development Companies Index, holding a concentrated basket of publicly traded BDCs that lend to middle-market firms at floating rates over SOFR. When those loans pay interest, the BDCs distribute nearly all of it to shareholders to preserve their tax status, and BIZD passes that income through quarterly. Roughly 90% or more of BDC loan books are floating rate, which is why the Fed’s 75 basis point cut since September 2025, taking the target to 3.75%, hits BIZD’s income at the source.

The Four Holdings That Decide BIZD’s Fate Ares Capital (NASDAQ:ARCC | ARCC Price Prediction), the largest BDC by market cap at $13.48 billion, held its quarterly dividend at $0.48 for the eighth straight quarter. Q1 core EPS of $0.47 fell a penny short, but net investment income of $0.55 per share gives real cushion. Non-accruals ticked up to 2.1% from 1.8%, worth watching, but a $1.8 billion investment backlog and $6 billion in liquidity support the payout.

Blue Owl Capital (NYSE:OBDC) already made the cut official. On May 5, 2026, the board dropped the base dividend from $0.37 to $0.31, a 16% reduction in annualized payout. CEO Craig Packer cited “a more challenging earnings environment driven by lower base rates and tighter spreads.” Adjusted EPS of $0.31 now exactly matches the new dividend, meaning zero buffer. Shares are down 15% over the past year.

Blackstone Secured Lending (NYSE:BXSL) looks like the next domino. NII of $0.77 covered the $0.77 dividend at exactly 100%, down from 104% in Q4. New investments are being originated at 7.7% while assets rolling off yielded 9.1%, which mechanically compresses future income. Non-accruals jumped to 3.1% of fair value from 0.6% a quarter earlier. CEO Brad Marshall’s own words: “non-accruals increased during the quarter from historically low levels.” Another miss, and BXSL follows OBDC.

Main Street Capital (NYSE:MAIN) is the fund’s insurance policy. Distributable NII of $1.00 per share comfortably covers the $0.26 monthly regular plus a $0.30 quarterly supplemental, now paid for 19 consecutive quarters. NAV per share rose to about $33. MAIN’s lower-middle-market focus and equity co-investments generate returns other BDCs can’t match. Retail readers who like this profile may also want our 7 Monthly Dividend Stocks report.

Total Return Reality Check BIZD’s trailing 12-month distributions of $1.52 look generous against a roughly $13 share price, but the fund is down 6% year-to-date on top of last year’s decline. The forward annualized rate has reset to $0.96, so shoppers pricing this off the trailing yield are anchored to a payout that has already stepped down.

The Verdict BIZD’s distribution is at risk of further reduction. OBDC is done cutting for now, but BXSL is running on fumes at 100% coverage with rising non-accruals, and ARCC’s cushion is thinner than a year ago. MAIN is the anchor doing the heavy lifting. For investors who need a predictable check, MAIN offers more coverage than the blended pass-through. BIZD still makes sense for someone who wants diversified BDC exposure and can tolerate a variable payout that reflects whatever the underlying managers can actually earn each quarter.

Contact [email protected] for any questions or corrections.
2026-07-13 01:36 28d ago
2026-07-12 19:43 28d ago
Paramount weighs California exodus after state's war on $110B Warner Bros. takeover
PARA Paramount Global
FMP Stock News
Original source text
California’s escalating battle over Paramount’s proposed $110-billion merger with Warner Bros. Discovery could end with another corporate giant walking away from the Golden State.

Sources told Semafor advisers close to CEO David Ellison have encouraged him to consider moving the company’s HQ and redirecting much of its planned $30 billion spending outside the state if Attorney General Rob Bonta files a lawsuit to block the deal.

California’s escalating battle over Paramount’s proposed $110-billion merger with Warner Bros. Discovery could end with another corporate giant walking away from the Golden State. Getty Images

If Paramount ultimately relocates, it would join a growing list of major companies that have moved their headquarters after disputes with California regulators. Getty Images for CinemaCon Paramount has already committed to keeping both the Paramount and Warner Bros. studio lots operational if the merged company remains in California.

Executives have argued the merger would preserve and create jobs by backing roughly $30 billion in annual content spending at a time when film and television production have shifted to other states and Canada, resulting in thousands of entertainment jobs leaving California.

One adviser described California as an “inhospitable” place for Paramount to operate and said a lawsuit challenging the merger could ultimately push the company to leave the state.

Despite those discussions, Ellison is not sold on leaving California. He moved Paramount’s headquarters from New York to Los Angeles after acquiring the company last year and has spent most of his life in the state.

If Paramount ultimately relocates, it would join a growing list of major companies that have moved their headquarters after disputes with California regulators.

Paramount has already committed to keeping both the Paramount and Warner Bros. studio lots operational if the merged company remains in California. Getty Images

Last year, Paramount signed a lease for nearly 300,000 square feet of studio space in Bayonne, N.J. Getty Images Chevron shifted its headquarters from San Ramon, Calif. to Texas two years ago, while Oracle and Tesla have also established headquarters in the Lone Star State.

The company also has another potential foothold outside California: Last year, Paramount signed a lease for nearly 300,000 square feet of studio space in Bayonne, N.J.

“We continue to engage constructively with the remaining few regulators around the world still considering the merger, including State Attorneys General, and are prepared to address any legitimate antitrust issues,” Paramount said in a statement.

“We are confident this transaction raises no such concerns, as demonstrated by the dozens of antitrust authorities around the world that have carefully reviewed the transaction,” the statement continued.

Download The California Post App, follow us on social, and subscribe to our newsletters California Post News: Facebook, Instagram, TikTok, X, YouTube, WhatsApp, LinkedIn
California Post Sports Facebook, Instagram, TikTok, YouTube, X
California Post Opinion
California Post Newsletters: Sign up here!
California Post App: Download here!
Home delivery: Sign up here!
Page Six Hollywood: Sign up here!
2026-07-13 01:35 28d ago
2026-07-12 21:06 28d ago
Why Monday.com Stock Collapsed 51% In The First Half of 2026
MNDY Monday.com
FMP Stock News
Original source text
Shares of Monday.com (MNDY 1.44%) fell a whopping 50.9% in 2026, according to data from S&P Global Market Intelligence. The software provider for business workflows has been deemed a massive loser due to the artificial intelligence (AI) revolution, which has brought down much of the software sector.

Despite this narrative, the company continues to deliver double-digit revenue growth. Does that make the stock a buy-the-dip candidate down 81% from highs?

Today's Change

(

-1.44

%) $

-1.20

Current Price

$

82.45

A narrative of AI disruption Software providers like Monday.com are taking a beating because of the rising threat of AI coding agents. The company offers software that helps managers divide tasks for work projects, usable by large and small teams alike. It is meant to help organize work in the digital age, and is especially beneficial for remote worker teams.

Investors' idea is that companies can use new AI coding tools like Claude Code to spin up their own copies of Monday.com for their businesses. This will lead to customer attrition and the eventual decline of Monday.com's business model.

It is this narrative entirely that has dragged down Monday.com stock, because the numbers it is putting up show no signs of disruption right now. Revenue grew by 24% year-over-year in the first quarter of 2026, with enterprise customers contributing more than $500,000 in annual recurring revenue (ARR), growing even faster, up 74% year-over-year. Profitability is also improving, with operating earnings doubling to around $20 million in the period.

Image source: Getty Images.

Time to buy the dip? After this drawdown, Monday.com now trades at a price-to-sales ratio (P/S) of just 3.3. For a company with strong gross margins of 89%, this could potentially prove a very cheap sales multiple if Monday.com can keep delivering revenue growth and bottom-line margin expansion at greater scale.

The big question is whether AI is actually disrupting the business. If it were, the numbers would point to enterprises churning away from Monday.com, when in fact the opposite is happening: enterprises are its fastest-growing segment. While AI software is a fast-moving field, it will likely not destroy Monday.com's business overnight, if it ever does.

These AI fears are placing a huge discount on enterprise software stocks compared to their historical averages. If you believe that Monday.com will skate through fine to the other side, shares look cheap enough to finally buy the dip for the rest of 2026 and beyond.
2026-07-13 01:18 28d ago
2026-07-12 20:30 28d ago
Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases
CMSA CMS Energy
FMP Stock News
Original source text
, /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, today announced an additional AI‑empowered drug discovery collaboration targeting a mass-market indication in central nervous system with an innovative mechanism of action (MoA) identified by PandaOmics.

According to the collaboration agreement, the two parties will jointly advance the co-development of the R&D program by combining Insilico Medicine's validated AI platform and AI-enabled innovative drug discovery and development capabilities with CMS's experienced R&D team and deep therapeutic expertise. Insilico Medicine is eligible to receive up to approximately 1.2 billion RMB in milestone payments plus royalties. This partnership marks a deepening collaboration that leverages both parties' complementary strengths across the full value chain—from drug discovery and clinical development to commercialization.

Mr. Lam Kong, the Chairman, Chief Executive Officer, President and Executive Director of CMS said: "CMS is deeply impressed by Insilico Medicine's capability and productivity in AI drug discovery. We are happy to deepen our collaboration with Insilico Medicine. Insilico Medicine's leadership in AI drug discovery platforms and data-driven R&D is strategically complementary to CMS's capabilities in innovative R&D and clinical translation. In addition, CMS has built solid strengths in clinical development systems and efficiency, regulatory submission expertise, and commercialization network coverage. Our goal never changes: to accelerate the delivery of more clinically meaningful innovations to patients with greater speed and quality, better meeting the growing clinical needs."

"We are delighted to establish another collaboration with China Medical System just three months after our initial announcement," said Feng Ren, PhD, Co-CEO and Chief Scientific Officer of Insilico Medicine. "Our existing partnership, announced earlier this year, has been seamless and productive since its inception. In this new program, we value the input from the CMS commercialization team and are proud of the innovative Mechanism of Action (MoA) identified by PandaOmics, which streamlines the development of high-potential drugs, enhancing translational efficiency, and accelerating the transition of molecules from 'proof of concept' to life-changing patient therapies. We will continue to deepen our multi-dimensional collaboration in pipeline and clinical strategy and global partnerships to provide patients with more differentiated and accessible treatment options."

About CMS

CMS (HKEX stock code:867; SGX stock code: 8A8) is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/gastroenterology/ophthalmology/ skin health businesses, bringing economies of scale in specialty fields.

About Insilico Medicine
Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend health longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.

By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit www.insilico.com

SOURCE Insilico Medicine
2026-07-13 01:15 28d ago
2026-07-12 20:40 28d ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBG
HUBG Hub Group
FMP Stock News
Original source text
NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of purchasers of securities of Hub Group, Inc. (NASDAQ: HUBG) between April 28, 2023 and May 11, 2026, inclusive (the “Class Period”), of the important August 28, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Hub Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Hub Group class action, go to https://rosenlegal.com/cases/hub-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that Hub Group’s financial statements prepared for the periods from Q1 2023 to Q4 2024, including annual reports for 2023 and 2024, contained material misstatements—caused by the premature and incorrect recognition of certain transactions—concerning, inter alia, Hub Group’s operating revenue, operating income, revenue recognition, effectiveness of internal controls and procedures, and drivers of financial results and growth. In addition, Hub Group’s financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements—caused by the understatement of purchased transportation costs and accounts payable —concerning, inter alia, Hub Group’s operating expenses, purchased transportation and warehousing expenses, operating income, effectiveness of internal disclosure controls and procedures, and drivers of financial results and growth. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Hub Group class action, go to https://rosenlegal.com/cases/hub-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
 275 Madison Avenue, 40th Floor
 New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
2026-07-13 01:13 28d ago
2026-07-12 19:02 28d ago
Unum Group Cuts Long-Term Care Risk With $3.8B Reinsurance Deal
UNM Unum Group
FMP Stock News
Original source text
The “Duck Stock” Keeps Quietly Making Money for ShareholdersUnum Group NYSE: UNM said it has agreed to reinsure an additional portion of its long-term care insurance liabilities, marking the company’s third major external reinsurance transaction and its second involving long-term care.

On a conference call with analysts, President and CEO Rick McKenney said the agreement will cede $3.8 billion of long-term care statutory reserves, bringing total long-term care reserves reinsured to $7 billion. He said the transactions have reduced Unum’s exposure by 40% compared with the beginning of last year.

Get Unum Group alerts:

These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?The transaction is effective April 1, 2026, and is expected to close during 2026, subject to regulatory approvals and other customary closing conditions, according to Matt Royal, senior vice president of investor relations and treasury.

Deal Removes Remaining Individual LTC in Fairwind McKenney said the transaction removes all of Unum’s individual long-term care business that was originally written by Unum America and subsequently reinsured to Fairwind. The remaining liabilities in Fairwind will be group long-term care, which management said has a different risk profile.

3 Dividend Stocks Defying the Market Downturn Amid the Iran ConflictChief Financial Officer Steve Zabel said the company is reinsuring $3.8 billion of long-term care statutory reserves to Fortitude Re. Similar to Unum’s prior long-term care reinsurance deal, the biometric risk ceded to Fortitude Re will be retroceded to a highly rated global reinsurer, he said.

Zabel said the reinsured block represents 26% of Unum’s total long-term care block and 52% of its individual long-term care business. It includes about 50,000 policies with an average attained age of 76 years, compared with 86 years for the block reinsured in last year’s transaction.

The block is concentrated in active life reserves, which account for about 75% of reinsured reserves. Zabel said it also has a “materially richer benefit profile” than the business Unum will retain, with 83% of policies carrying inflation protection and 43% offering lifetime benefits.

Capital Cost and Pricing McKenney said the transaction will cost Unum $650 million of holding company excess capital, which he described as balanced against the risk reduction achieved. He also said Unum’s plan to return $1.3 billion to shareholders through dividends and share repurchases remains intact.

Zabel said management believes the most appropriate way to evaluate the transaction is relative to best estimate reserves, because that measure reflects the exposure being transferred. On that basis, he said the cost of the transaction is about 12% of best estimate reserves, compared with 10% for the 2025 transaction. The combined cost across both transactions is about 11%.

Zabel said the absolute cost relative to statutory reserves is higher because the 2026 block has a more adverse reserve profile. He said the block carries best estimate reserves nearly $700 million higher than statutory reserves, including a negative reserve margin of about $660 million.

Management said economic benefits from the deal include required capital release and tax benefits, which offset a significant portion of the gross cost. Zabel also said Unum is using temporary financing tied to future tax benefits that are expected to be realized over the next several years.

Remaining Long-Term Care Block Following the transaction, Unum’s total long-term care statutory reserves will decline from $14.8 billion to approximately $11 billion, according to Zabel. Group long-term care will represent about 70% of remaining long-term care reserves and 95% of insured lives.

Zabel said the shift toward group long-term care is “structurally important” because the group business carries less rich benefit designs, younger attained ages and lower ultimate risk than individual long-term care. He said the average daily benefit on group long-term care is about one-third of individual long-term care. He also said 77% of group long-term care policies have no inflation protection and only 7% have lifetime benefits.

Management said the transaction reduces sensitivities across key Fairwind assumptions, including premium rate increases, lapses and mortality, claim incidence, claim resolutions and interest rates. Zabel said those sensitivities decrease by 28% to 42%.

After the transaction, Fairwind will retain approximately $7.1 billion of group long-term care reserves, supported by about $2.1 billion of reserve margin and total protection of about $1.9 billion, Zabel said. Provident Life will continue to hold the remaining long-term care exposure, supported by diversification from a broader and growing product portfolio.

Capital Deployment Plans Unchanged Zabel said Unum expects year-end 2026 capital metrics to remain robust, including risk-based capital in the range of 400% to 425%, holding company liquidity of $1.5 billion to $2 billion and leverage of about 25%.

He said Unum’s 2026 capital sources and uses are unchanged, including expected capital generation of $1.4 billion to $1.6 billion and expected uses of about $1.5 billion, inclusive of roughly $1.3 billion of share repurchases and dividends.

“There is no change to our priorities, no change to our planned actions, and no change to our expected return of capital to shareholders this year as a result of the transaction,” Zabel said.

Analysts Ask About Future LTC Actions During the question-and-answer session, analysts asked whether Unum could pursue additional long-term care reinsurance transactions, including for group long-term care. McKenney said the company continues to talk to counterparties about different parts of the block but emphasized that future deals would depend on market conditions and shareholder value.

“We would like to remove that risk from our balance sheet overall,” McKenney said of long-term care. “At the same time, we’ve also been very clear to say we’ll only do so if it makes sense from a shareholder perspective.”

McKenney said Unum remains focused on its core employee benefits franchises in the U.S., U.K. and Poland while continuing to manage the closed long-term care block. He described the new agreement as “another meaningful step” in the company’s closed block strategy.

About Unum Group NYSE: UNMUnum Group NYSE: UNM is a leading provider of employee benefits in the United States and selected international markets, specializing in disability, life, accident and critical illness insurance. Through both fully insured and self-funded arrangements, the company offers group coverage designed to protect income and mitigate financial hardship for employees and their families. Its portfolio includes short-term and long-term disability plans, group life and accidental death & dismemberment (AD&D) policies, as well as critical illness and hospital indemnity products.

In addition to its core product lines, Unum Group markets voluntary benefits under its Colonial Life brand, allowing employees to purchase supplemental insurance such as accident, cancer, and dental coverage directly through payroll deductions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Unum Group Right Now?Before you consider Unum Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unum Group wasn't on the list.

While Unum Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
2026-07-13 01:12 28d ago
2026-07-12 12:00 28d ago
Bronstein, Gewirtz & Grossman LLC Urges ChampionX Corporation Investors to Act: Class Action Filed Alleging Investor Harm
CHX ChampionX
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CHX.

ChampionX Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

while repurchasing millions of dollars' worth of ChampionX Corporation ("ChampionX" or the "Company") common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited ("SLB") to acquire ChampionX at a premium to prevailing market prices; Defendants failed to either abstain from trading or disclose SLB's offer(s), which, if disclosed, would have signaled to investors that ChampionX's stock was worth significantly more than its trading price; Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for ChampionX Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CHX, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to ChampionX Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297987

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 01:11 28d ago
2026-07-12 12:00 28d ago
Bronstein, Gewirtz & Grossman LLC Urges CommVault Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
CVLT CommVault Systems
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against CommVault Systems, Inc. (NASDAQ: CVLT) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CommVault securities between April 29, 2025 and January 26, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CVLT.

CommVault Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Defendants provided investors with misleading guidance and projections regarding CommVault's anticipated annual recurring revenue ("ARR") growth for fiscal year 2026, including projections related to new net ARR growth; Defendants simultaneously disseminated overly positive statements while concealing material adverse facts concerning the true state of the Company's ARR growth environment; Defendants knew or recklessly disregarded that the Company's ARR growth guidance failed to properly account for critical variables, including the type of sales driving ARR performance; and as a result, Defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis and were materially false and misleading at all relevant times.What's Next for CommVault Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CVLT, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in CommVault you have until July 17, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to CommVault Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for CommVault Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298058

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 01:11 28d ago
2026-07-12 19:55 28d ago
JULY 17, 2026 DEADLINE: Commvault Systems, Inc. (CVLT) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CVLT CommVault Systems
FMP Stock News
Original source text
San Diego, California--(Newsfile Corp. - July 12, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Commvault Systems, Inc. (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, both dates inclusive (the "Class Period"), have until Friday, July 17, 2026 to seek appointment as lead plaintiff of the Commvault class action lawsuit. Captioned Imbert v. Commvault Systems, Inc., No. 26-cv-05654 (D.N.J.), the Commvault class action lawsuit charges Commvault and certain of Commvault's current and former executive officers with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the Commvault class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-commvault-systems-inc-class-action-lawsuit-cvlt.html

You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].

CASE ALLEGATIONS: Commvault provides cyber resiliency solutions for enterprises to protect, secure, and recover data, applications, and identity systems.

The Commvault class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that Commvault's annualized recurring revenue ("ARR") growth would remain steady throughout fiscal year 2026; (ii) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; and (iii) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, Commvault's projected net new ARR should not have been determined without properly factoring in sale type.

The Commvault class action lawsuit further alleges that on January 27, 2026, Commvault released its third quarter 2026 financial results, revealing net new ARR of $39 million, below Commvault's previously guided $45 million. On this news, the price of Commvault stock fell more than 31%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Commvault securities during the Class Period to seek appointment as lead plaintiff in the Commvault class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Commvault class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Commvault class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Commvault class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors — $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever — $7.2 billion — in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Contact:
Robbins Geller Rudman & Dowd LLP
Ken Dolitsky
Michael Albert
655 W. Broadway, Suite 1900, San Diego, CA 92101
800/851--7783
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304816

Source: Robbins Geller Rudman & Dowd LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 01:08 28d ago
2026-07-12 21:00 28d ago
First Hawaiian to Report Second Quarter 2026 Financial Results on July 24, 2026
FHB First Hawaiian
FMP Stock News
Original source text
July 12, 2026 21:00 ET  | Source: First Hawaiian, Inc.

HONOLULU, July 12, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its second quarter 2026 financial results on Friday, July 24, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time).

To access the call by phone, participants will need to click on the following registration link: https://register-conf.media-server.com/register/BIb8e318d9b8d24417b3d7d113fcf80dbc, register for the conference call, and then you will receive the dial-in number and a personalized PIN code. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time.

A live webcast of the conference call, including a slide presentation, will be available at the following link: www.fhb.com/earnings. The archive of the webcast will be available at the same location.

About First Hawaiian

First Hawaiian, Inc. (NASDAQ:FHB) is a bank holding company headquartered in Honolulu, Hawaii. Its principal subsidiary, First Hawaiian Bank, founded in 1858 under the name Bishop & Company, is Hawaii’s oldest and largest financial institution with branch locations throughout Hawaii, Guam and Saipan. The company offers a comprehensive suite of banking services to consumer and commercial customers including deposit products, loans, wealth management, insurance, trust, retirement planning, credit card and merchant processing services. Customers may also access their accounts through ATMs, online and mobile banking channels. For more information about First Hawaiian, Inc., visit www.fhb.com.

Investor Relations Contact:
Kevin Haseyama
(808) 525-6268
[email protected]

Media Contact:
Bill Weeshoff
(808) 525-6229
[email protected]
2026-07-13 00:45 28d ago
2026-07-12 12:00 28d ago
Bronstein, Gewirtz & Grossman LLC Urges Verra Mobility Corporation Investors to Act: Class Action Filed Alleging Investor Harm
VRRM Verra Mobility
FMP Stock News
Original source text
New York, New York--(Newsfile Corp. - July 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Verra Mobility Corporation (NASDAQ: VRRM) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Verra securities between February 24, 2026 and May 26, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/VRRM.

Verra Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Defendants misrepresented the nature and stability of Verra's relationship with Avis Budget Group ("Avis"), including the likelihood of securing a contract extension; Defendants downplayed the risk that major rental car companies, including Avis, could replace Verra's services with in-house solutions or alternative third-party providers; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for Verra Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/VRRM, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Verra you have until August 4, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Verra Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Verra Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300547

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-07-13 00:37 28d ago
2026-07-12 20:24 28d ago
BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit
BMI Badger Meter
FMP Stock News
Original source text
, /PRNewswire/ -- 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Badger Meter, Inc. (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.

So what: If you purchased Badger Meter common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Badger Meter class action, go to https://rosenlegal.com/cases/badger-meter-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements concerning the drivers of Badger Meter's "record" financial results, demand for Badger Meter's products, and its prospects for continued growth. During the Class Period, defendants told investors that Badger Meter's strong financial results reflected "ongoing favorable industry trends," "secular growth drivers," and "solid operating execution." They likewise touted "strong" demand and said they were seeing "robust order pacing and a strong bid pipeline that positions us well for continued sales and earnings growth," and that Badger Meter possessed a "long runway" for growth.

According to the lawsuit, these statements were materially false and misleading. In truth, Badger Meter's financial results during the Class Period were at least partially attributable to Badger Meter's practice of pulling-forward customer orders to recognize revenue early, which concealed weakening demand and deteriorating near-term order trends. This practice also depleted revenue otherwise available for future periods, ultimately causing the disappointing financial results Badger Meter later reported. When the true details entered the market, the lawsuit claims that investors suffered damages. 

To join the Badger Meter class action, go to https://rosenlegal.com/cases/badger-meter-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.
2026-07-12 23:46 28d ago
2026-07-12 17:50 28d ago
An Astera Labs Insider Sold at $458, but the 93% Revenue Growth Is the Real Story
ALAB Astera Labs
FMP Stock News
Original source text
Manuel Alba, a Director at Astera Labs, Inc. (ALAB 1.07%), executed a sale of 8,491 shares of common stock on July 1, 2026, according to an SEC Form 4 filing.

Transaction summaryMetricValueTransaction value$3.9 millionShares sold (indirectly held)8,491Post-transaction shares (directly held)2,351Post-transaction shares (indirectly held)291,863Transaction value based on SEC Form 4 weighted average sale price ($458.38); post-transaction value based on July 1, 2026 market close ($430.86).

Key questionsWhat was the mechanism for this transaction?
The sale was executed automatically under a Rule 10b5-1 trading plan that Manuel Alba adopted on May 29, 2025, which allows insiders to schedule trades in advance to avoid concerns regarding material non-public information.How are the remaining shares held?
The vast majority of the reported equity is held indirectly, with 286,863 shares owned by Casa Alameda 2007, LLC, where the Director serves as manager, and 5,000 shares held by a spouse.What is the recent performance context for the company?
As of July 2, 2026, shares were priced at $406.42, following a period of appreciation where the stock delivered a 386% total return in the year leading up to the transaction date.What is the company's current financial profile?
Headquartered in Santa Clara, the company operates in the semiconductor industry with a market capitalization of $70 billion and reported trailing twelve-month revenue of $1.0 billion as of July 7, 2026.Company OverviewMetricValueShare Price (as of market close 2026-07-02)$406.42Market Capitalization$69.7 billionRevenue (TTM)$1.0 billionNet Income (TTM)$267.6 millionCompany SnapshotAstera Labs develops and markets semiconductor-based connectivity solutions through its Intelligent Connectivity Platform, which comprises data, network, and memory connectivity products designed to serve cloud computing and artificial intelligence infrastructure markets.The company generates revenue through a software-defined architecture approach that enables customers to deploy and operate high-performance cloud and AI systems at scale, leveraging proprietary semiconductor technology and integrated software solutions.The company primarily serves hyperscale cloud service providers and enterprise customers requiring advanced connectivity infrastructure for AI and cloud computing applications.Astera Labs is a semiconductor connectivity specialist founded in 2017 that has achieved significant scale with $1.0 billion in TTM revenue and a market capitalization of $69.7 billion. The company's Intelligent Connectivity Platform addresses critical infrastructure bottlenecks in cloud and AI deployments, positioning it at the intersection of two of the highest-growth technology markets. With a lean operational footprint of 440 employees and TTM net income of $267.6 million, Astera Labs demonstrates strong operational leverage and profitability in a capital-intensive industry.

What this transaction means for investorsThis sale ultimately seems like a director trimming a rounding error off a very large win, and the proportions make that clear. Alba let go of 8,491 shares under a plan he set more than a year ago, but he still controls roughly 292,000 shares, almost all of it held through an LLC he manages. Given that the director parted with under 3% of his position on a preset schedule, selling at $458 after this kind of run is nothing to read too deeply into.

That’s also partly because the business is firing on every cylinder. Astera's first-quarter revenue hit a record $308.4 million, up 93% from a year earlier, with PCIe 6 products now more than a third of the mix and non-GAAP operating margin near 36%. CEO Jitendra Mohan tied the growth to demand for the company's connectivity platform and its new Scorpio switches ramping into the second half. Of course, it’s important to watch valuation after this kind of run-up. At a $70 billion market cap after a year in which shares have basically quadrupled, this stock is priced for years of what investors might expect to be flawless execution, so any dwindling expectations could lead to a strong reset in the stock’s price.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool recommends Astera Labs. The Motley Fool has a disclosure policy.
2026-07-12 23:41 28d ago
2026-07-12 19:00 28d ago
Apple's ‘Thermonuclear' Response to the OpenAI Threat
AAPL Apple
FMP Stock News
Original source text
Apple's suit against OpenAI under Tim Cook echoes a familiar playbook, betting that litigation can delay a rival from upending the iPhone era.
2026-07-12 23:41 28d ago
2026-07-12 19:23 28d ago
Meta Shuts Down AI Image Tool Following Backlash
FB Meta Platforms
FMP Stock News
Original source text
By PYMNTS  |  July 12, 2026

 | 

Meta has shuttered an artificial intelligence image creation feature after just three days, following public backlash.

The tech giant last Tuesday (July 7)  introduced a tool that let users generate images using public Instagram accounts. By Friday (July 10), the feature was pulled, after Meta received widespread privacy-related criticism.

“Our intent was to provide a useful creative tool and to give people control over whether their public content could be referenced in this way,” Meta said in a statement shared by Reuters. “We’ve heard the feedback that this feature missed the mark, so it’s no longer available.”

According to Reuters, the feature had faced backlash related to privacy concerns. It had allowed anyone to generate an image of another person by public Instagram username in a prompt. Public accounts had been included by default unless users navigate to a setting to opt out.

As covered here last week, Meta’s own policy states that users “will not be notified about content created using AI features at Meta.”  The opt-out also did not apply retroactively, meaning that images generated before a user turns off the setting remain in the system.

“That distinction matters because most users will not find the setting, and some who look for it on launch day could not locate it at all,” PYMNTS wrote.

“Public photos posted for an audience of followers become reusable inputs for AI generation by strangers, advertisers and Meta’s own ad system without any action required from the account holder. The feature is free to use. The identity data powering it belongs to the people who posted it. Whether they agreed to that use is now a question for regulators in multiple jurisdictions.”

According to the Reuters report, SAG-AFTRA, the union representing actors and other media professionals, urged its members and other Instagram users to opt out of the feature.

“Anything other than a clear and conspicuous opt-in for these types of uses of Instagram users’ images is unacceptable, and an utter miscalculation of public sentiment regarding the obvious dangers and harms inherent in such use,” SAG-AFTRA said.

In the wake of Meta’s decision to remove the feature, a spokesperson for the union welcomed the move, calling it “the responsible thing to do.”

As PYMNTS noted last week, this is happening as Meta faces enormous pressure to show that its AI investments are generating revenue. The company in April forecast AI capital expenditures of $115 billion to $135 billion for 2026, almost double last year’s amount.
2026-07-12 23:39 28d ago
2026-07-12 18:47 28d ago
Should You Buy the Dip in Nvidia Stock?
NVDA Nvidia
FMP Stock News
Original source text
Nvidia's (NVDA +3.90%) market price hasn't increased as significantly as some of its peers.

*Stock prices used were the afternoon prices of July 9, 2026. The video was published on July 11, 2026.

Parkev Tatevosian, CFA has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
2026-07-12 23:37 28d ago
2026-07-12 17:00 28d ago
Is PayPal Stock a Bargain or a Value Trap?
PYPL PayPal
FMP Stock News
Original source text
PayPal has seen solid revenue growth, but weak margins have weighed on the stock. PayPal could be able to buy back all its shares with free cash flow over the next several years.
2026-07-12 23:36 28d ago
2026-07-12 18:02 28d ago
Teva Pharmaceutical Industries' Anti-IL-15 Antibody Shows Promise in Vitiligo Study
TEVA Teva Pharmaceutical
FMP Stock News
Original source text
MarketBeat Week in Review – 02/03 - 02/07Teva Pharmaceutical Industries NYSE: TEVA said its internally developed anti-IL-15 antibody produced encouraging 24-week efficacy results in a phase 1b proof-of-concept study for vitiligo, as the company highlighted the program as part of its broader shift toward a biopharma-focused growth strategy.

During a conference call, President and CEO Richard Francis called the data “a milestone” in Teva’s “Pivot to Growth” plan and said 2026 is expected to include eight key events for the company, up from a prior expectation of seven following the addition of an ecopipam NDA filing.

Get TEVA alerts:

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy NowFrancis said Teva’s pipeline includes several programs that the company believes could each become $1 billion products in their respective indications, including anti-IL-15, duvakitug, emricasan, DARI, ecopipam and olanzapine-related programs. He said Teva expects its innovative portfolio to generate $3.5 billion of revenue in 2026.

Vitiligo Study Shows Facial and Total Body Responses Eric A. Hughes, Teva’s EVP of Global R&D and Chief Medical Officer, said vitiligo is an autoimmune disease in which an immune reaction destroys melanocytes, leading to loss of pigmentation. He said the disease affects about 0.5% to 2% of the global population and carries a psychological burden, including anxiety, depression and social isolation.

2 Generic Drug Stocks Ready to Surge in 2025Hughes said the only FDA-approved treatment currently available is a topical therapy for patients with less than 10% body surface area involvement, leaving a need for systemic options that can treat the whole body.

The phase 1b study evaluated Teva’s anti-IL-15 antibody in approximately 38 patients. Participants received one subcutaneous dose at day zero and another at week 12, with efficacy measured at 24 weeks. Hughes said 66% of patients in the study had skin involvement greater than 10% of their body surface area.

Teva reported the following 24-week results after two doses:

42% of patients achieved F-VASI50, representing at least a 50% improvement in facial vitiligo. 21% of patients achieved F-VASI75, representing at least a 75% improvement in facial vitiligo. 7% of patients achieved T-VASI50, representing at least a 50% improvement in total body vitiligo. 75% of patients reported improvement in facial skin using the facial Patient Global Impression of Change score, with half of those reporting “much” to “very much” improvement. 55% of patients reported improvement in total skin using the total Patient Global Impression of Change score. Hughes said the patient-reported outcomes were particularly meaningful because patients monitor their skin daily and may be strongly affected by changes in appearance.

Company Highlights Quarterly Dosing Potential Hughes said Teva believes its anti-IL-15 antibody is differentiated by its potency, long half-life and target engagement. He described the molecule as “Teva-born” and said it was created by the same internal team that developed duvakitug.

According to Hughes, the antibody has a half-life of about 38 days. He said the company observed rapid suppression of free IL-15 levels in serum within one or two days, and at the top dose, suppression below the limit of quantitation extended to about 80 to 90 days. Based on those data, Hughes said dosing once per quarter is a “strong possibility.”

Hughes said the drug has been “very well tolerated” to date, with no safety signals seen so far. In response to an analyst question, he said Teva has followed patients from earlier studies for extended periods, including out to about 400 days in some phase 1 work, and has not seen adverse events associated with IL-15 rebound as levels return to baseline.

Teva Compares Data With Oral JAK Programs Hughes compared the phase 1b results with published data from upadacitinib, an oral JAK therapy that he said recently received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use.

He said Teva’s F-VASI50 result of 42% compared with 38% and 39% in the upadacitinib data he referenced. Teva’s F-VASI75 result of 21% compared with 19% and 14%, while its T-VASI50 result of 7% compared with 6% and 11%.

Hughes said Teva views the comparison as encouraging, particularly because its product is being developed as a subcutaneous injection given once every quarter. He contrasted that with daily oral JAK therapy, which he said carries a black box warning.

Phase 2 Plans and Additional Indications Teva said it has already met with the FDA and is incorporating the agency’s feedback into a phase 2 study expected to begin this year. Hughes said the company plans dose-ranging work in phase 2b and is discussing a seamless study design that could allow the program to move efficiently toward phase 3.

Hughes said Teva expects facial VASI and total VASI endpoints to be used in later-stage development, with baseline criteria likely to include greater than 0.5 on facial VASI and greater than five on total VASI. He also said Teva will continue monitoring phase 1b subjects out to 80 weeks.

Teva also emphasized potential applications for anti-IL-15 beyond vitiligo. Hughes said IL-15 may be relevant in alopecia areata, celiac disease, eosinophilic esophagitis and atopic dermatitis. The company expects proof-of-concept data from a phase 2a celiac disease study in the second half of the year.

That celiac study, Hughes said, includes about 50 patients in a placebo-controlled gluten challenge design. Patients receive either active treatment or placebo, then undergo a gluten diet challenge, with biopsies used to evaluate effects on gut histology. Hughes said the crypt depth-to-villus height ratio will be the most important readout.

Francis closed the call by saying the anti-IL-15 vitiligo data represent the second of eight expected milestones for Teva this year, with additional pipeline updates anticipated in the coming months.

About Teva Pharmaceutical Industries NYSE: TEVATeva Pharmaceutical Industries Ltd. NYSE: TEVA is an Israeli multinational pharmaceutical company and one of the world's largest manufacturers of generic medicines. The company's core activities include the development, production and marketing of generic pharmaceuticals alongside a portfolio of specialty branded medicines. Teva supplies finished dosage forms and active pharmaceutical ingredients (APIs) to markets around the globe and operates manufacturing and research facilities in multiple countries.

Teva's product range covers oral solids, injectables, inhalation products and other dosage forms across therapeutic areas such as central nervous system disorders, respiratory, oncology, pain and infectious disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Teva Pharmaceutical Industries Right Now?Before you consider Teva Pharmaceutical Industries, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teva Pharmaceutical Industries wasn't on the list.

While Teva Pharmaceutical Industries currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
2026-07-12 23:25 28d ago
2026-07-12 18:05 28d ago
Best Artificial Intelligence (AI) Stock: AMD, Nvidia, or Broadcom
AVGO Broadcom
FMP Stock News
Original source text
If you asked me at the start of the year how I would rank Advanced Micro Devices (AMD +2.13%), Broadcom (AVGO 0.31%), and Nvidia (NVDA +3.90%) in terms of potential stock performance, I would have put Nvidia at the top, Broadcom in the middle, and AMD in last place. So far in 2026, my projection that Broadcom would be in the middle has panned out, but AMD has been a massive winner while Nvidia has been a loser.

There's still a lot of time left in 2026, but which one of these three artificial intelligence (AI)-related stocks is the best buy now?

Let's take a look at this trio and rerank them for the rest of 2026 and into 2027.

Image source: Getty Images.

AMD and Nvidia are competing in the same field All three of these stocks are being heavily spurred on by massive AI spending. AMD and Nvidia approach this problem from the same perspective, as each offers graphics processing units (GPUs) that excel in computing scenarios with variable, complex workloads. However, Nvidia's products have downright dominated the field to date, and it holds a commanding lead in the data center space.

Today's Change

(

2.13

%) $

11.62

Current Price

$

558.34

Broadcom is taking a completely different approach. Instead of a broad-purpose computing unit like a GPU, it has partnered directly with a handful of AI hyperscalers to design a custom AI chip tailored to the workloads each firm sees. This creates a chip that often offers better cost-performance than GPU-based computing, driving its rising popularity.

Broadcom expects major growth next year as new clients launch their custom AI chips. Currently, Broadcom's major customer is Alphabet, with its Tensor Processing Units (TPUs). However, Broadcom is also making custom AI chips for Meta Platforms, Anthropic, and OpenAI, and production for those chips is scheduled to ramp up late this year and into next.

Today's Change

(

-0.31

%) $

-1.25

Current Price

$

399.87

So, which of these is the best horse to back from a business approach? I'm still bearish on AMD, as it has a major uphill battle to win space in data centers when so many ecosystems have already been developed around Nvidia's. Between Nvidia and Broadcom, it's tough because many companies will stick with GPU-based training for its flexibility. Still, custom AI chips will likely become quite popular over the next few years as AI hyperscalers look to optimize their spending. As a result, I'm giving this one to Nvidia and Broadcom as a tie.

Winners: Nvidia and Broadcom

Nvidia is still dominating the growth game From a growth standpoint, Nvidia still stands alone at the top, growing far faster than the other two.

Data by YCharts.

Looking ahead, the market still expects Nvidia to maintain its lead for the full fiscal year, though Broadcom is starting to close the gap.

Data by YCharts.

AMD is still well behind Nvidia, and while I think Broadcom is still a strong pick, Nvidia will likely retain its rapid-growth title for some time.

Winner: Nvidia

AMD's stock is outrageously expensive Lastly, let's look at valuation. Because all three of these stocks are rapidly growing, the best way to value them is by using earnings projections. For the current fiscal year, AMD's stock is far more expensive than either Broadcom's or Nvidia's. Furthermore, Broadcom is also more than 50% more expensive than Nvidia's.

Data by YCharts.

If we use next fiscal year's projections, the trend remains the same: Nvidia's stock looks dirt cheap compared to the other two.

Data by YCharts.

Clearly, Nvidia is the winner here as well.

Winner: Nvidia

Investors should sell AMD shares for Nvidia shares I think the biggest takeaway here is that AMD's 2026 rally has likely gotten ahead of itself, and investors are discounting Nvidia far too much, as its display is being far more successful than AMD's. Broadcom is still a solid stock pick with strong growth head, but it just isn't as good a deal as Nvidia right now.
2026-07-12 22:52 28d ago
2026-07-12 18:00 28d ago
What This Invesco Insider Move Signals With the Stock Up 63%
IVZ Invesco
FMP Stock News
Original source text
Jeffrey H. Kupor, a senior managing director of Invesco Ltd. (IVZ +1.29%), executed a non-discretionary disposition of 26,002 shares on July 2, 2026, according to an SEC Form 4 filing.

Transaction summaryMetricValueShares sold26,002Transaction value$702,314Post-transaction shares (directly held)125,818Post-transaction value$3.4 millionTransaction value based on SEC Form 4 weighted average sale price ($27.01); post-transaction value based on July 02, 2026 market close ($27.01).

Key questionsWhat was the specific nature of this disposition?
The transaction was executed for the sole purpose of covering tax withholding liabilities associated with the vesting of restricted stock units. Because these shares were withheld by the company to meet regulatory requirements, the move was non-discretionary and did not involve an open-market sale.What is the scale of the insider's remaining equity exposure?
Following this transaction, Jeffrey H. Kupor maintains a direct ownership stake of 125,818 shares. At the July 6, 2026 market close price of $27.83, this remaining position is valued at approximately $3.5 million, ensuring continued alignment with company performance.How has the stock performed leading up to this vesting event?
As of the July 2, 2026 transaction date, Invesco had delivered a one-year total return of 63%. Company OverviewMetricValueShare Price (as of market close 2026-07-06)$27.83Market Capitalization$12.2 billionRevenue (TTM)$6.6 billionNet Income (TTM)-$243.4 millionCompany SnapshotInvesco offers a comprehensive suite of investment products, including mutual funds, unit trusts, exchange-traded funds, closed-end funds, and retirement plans, generating revenue through asset management fees and advisory services.The company operates a diversified asset management business model that generates recurring revenue through management fees charged on assets under management across multiple product categories and geographic markets.Invesco serves institutional investors, financial advisors, and retail investors globally, with a focus on providing scalable investment solutions across equities, fixed income, alternatives, and multi-asset strategies.Invesco Ltd. is a global asset management firm operating from its Atlanta headquarters. The company has established a diversified financial services platform spanning multiple asset classes and distribution channels, positioning itself as a significant player in the competitive asset management industry. With TTM revenue of $6.6 billion, Invesco leverages scale and product breadth to compete across institutional and retail segments.

What this transaction means for investorsThis sale ultimately isn't the kind that should register on anyone's radar, because Kupor didn't actually choose to sell anything. These shares were withheld by Invesco to cover the taxes owed when his restricted stock vested, a bookkeeping step that happens automatically the moment the units convert.

With the noise cleared, what's left is a business seemingly hitting its stride. Invesco recently posted its 11th straight quarter of positive organic growth, pulling in nearly $22 billion of net inflows and ending the quarter at $2.2 trillion in assets. Adjusted earnings rose to $0.57 per share from $0.44 one year earlier, and the board raised the dividend and authorized another $1 billion buyback. CEO Andrew Schlossberg pointed to broad demand across the platform. For long-term investors, the takeaway is to ignore this filing, and instead watch flows and fee rates, especially whether QQQ outflows reverse, since that's what actually moves Invesco.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-07-12 22:50 28d ago
2026-07-12 18:18 28d ago
What's Behind a $211,680 CEO Sale at Vicor While AI Demand Drives 20% Revenue Growth?
VICR Vicor Corporation
FMP Stock News
Original source text
Patrizio Vinciarelli, the chairman & CEO of Vicor Corporation (VICR 1.94%), sold 700 shares of common stock at $302.40 per share for a total value of $211,680 on July 6, 2026, according to an SEC Form 4 filing.

Transaction summaryMetricValueTransaction value$211,680Shares sold (direct)700.0Post-transaction shares (total)8,514,515Post-transaction shares (directly held)8,347,390Post-transaction shares (indirectly held)167,125Key questionsWhat was the underlying mechanism for this transaction?
The sale was executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Vinciarelli on February 26, 2026, which allows insiders to set a predetermined schedule for stock sales to avoid concerns regarding material non-public information.How do the insider's total equity holdings break down post-transaction?
Vinciarelli retains direct ownership of 8,347,390 shares and indirect ownership of 167,125 shares held as Trustee for the Patrizio Vinciarelli Irrevocable Trust U/A Dated 12/21/2012, which was established for the benefit of his child.In what market context did this disposal occur?
The shares were sold at $302.40 per share, while the equity maintained a one-year return of close to 500% as of the July 6, 2026 transaction date.What is the company's current financial profile?
Vicor Corporation reported trailing twelve-month revenue of $471.7 million and net income of $136.7 million, operating as a designer and manufacturer of modular power components with a market capitalization of $11.3 billion as of the July 6, 2026 market close.Company OverviewMetricValueShare Price (as of market close 2026-07-06)$285.34Market Capitalization$11.3 billionRevenue (TTM)$471.7 millionNet Income (TTM)$136.7 millionCompany SnapshotVicor Corporation designs, manufactures, and distributes modular power components and systems, including brick-format DC-DC converters and complementary power management solutions that efficiently convert electrical power for diverse industrial and commercial applications.The company generates revenue through the sale of specialized power conversion and management products to original equipment manufacturers and system integrators across multiple end markets, leveraging its proprietary technology and manufacturing capabilities.Vicor serves a global customer base spanning the United States, Europe, Asia Pacific, and other international markets, targeting industries requiring high-performance power conversion solutions for mission-critical applications.Vicor Corporation is a leading provider of modular power conversion solutions with a market capitalization of $11.3 billion and TTM revenues of $471.7 million. The company maintains a strong operational footprint with 1,074 employees and demonstrates robust profitability, generating $136.7 million in net income over the trailing twelve months. Vicor's competitive positioning is anchored in its specialized expertise in power component design and manufacturing, enabling it to serve demanding applications where efficiency and reliability are paramount.

What this transaction means for investorsVinciarelli parted with 700 shares while still holding more than 8.3 million directly, so he sold roughly eight-thousandths of a percent of his stake under a plan he set in February. When someone sitting on a multibillion-dollar position lets a sliver go on a preset schedule, it’s not worth finding a signal to read into it. Yes, he's been selling out more aggressively since November (when he reported close to 10 million shares), but again, he still owns a very large stake.

Meanwhile, Vicor has had strong demand behind its recent stock run. The company’s first-quarter revenue rose 20% to $113 million as its power modules found their way into AI accelerators, and the real eye-opener was a one-year backlog that jumped 70% in a single quarter to $301 million, with bookings running above two times billings. Vinciarelli attributed the growth to rising demand across high-performance compute, automatic test equipment, and industrial, aerospace, and defense applications, and management guided to roughly $570 million in revenue for 2026 and is planning a second fab to break capacity constraints.

For long-term investors, the insider sale is noise. The signal is whether Vicor can build fast enough to convert that backlog, and whether its high-margin licensing business, currently on hold pending 2027 litigation, per the latest earnings call, becomes the real prize.

Read Next

About the Author

Jonathan Ponciano is a contributing stock market analyst at The Motley Fool. He has nearly a decade of experience as a financial journalist, most recently as an editor and senior reporter at Forbes focused on markets, technology, and entrepreneurship. Jonathan has also written for Investopedia and the Los Angeles Business Journal. He holds a dual B.A. in Business Journalism and Economics from the University of North Carolina at Chapel Hill and an M.B.A. from Columbia Business School. A North Carolina native now based in New York City, Jonathan has also lived in Mexico City and Los Angeles.
2026-07-12 22:47 28d ago
2026-07-12 17:59 28d ago
CVLT DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Commvault Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 17 Deadline in Securities Class Action - CVLT
CVLT CommVault Systems
FMP Stock News
Original source text
NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between January 28, 2025 and January 26, 2026, inclusive (the “Class Period”), of the important July 17, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Commvault securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 17, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Commvault’s competitive positioning was materially weaker than defendants had represented to investors; (2) due to the undisclosed increase in competition, Commvault was forced to make significant concessions on price and contract duration for its software licenses; (3) as these concessions became unsustainable, Software as a Service (“SaaS”) became a larger portion of Commvault’s sales mix; (4) in turn, the increasing mix of SaaS sales, which carry shorter term durations and lower average selling prices (“ASPs”), negatively impacted Commvault’s margin and Net New ARR (“NNARR”); and (5) as a result, defendants’ positive statements about Commvault’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
2026-07-12 22:38 28d ago
2026-07-12 17:48 28d ago
ROSEN, A LEADING NATIONAL FIRM, Encourages Peabody Energy Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTU
BTU Peabody Energy
FMP Stock News
Original source text
NEW YORK, July 12, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Peabody Energy Corporation (NYSE: BTU) between October 14, 2024 to May 4, 2026, inclusive (the “Class Period”), of the important August 24, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Peabody Energy common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Peabody Energy class action, go to https://rosenlegal.com/cases/peabody-energy-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Peabody Energy’s Centurion mine and the multitude of issues causing delays to the ramp-up and the return to full longwall production dates. On March 30, 2026, Peabody Energy issued a press release lowering guidance pertaining to Centurion mine’s expected first quarter 2026 output ahead of Peabody Energy’s full earnings release. In pertinent part, defendants announced that sales volume from the Centurion mine was expected to deliver approximately 250,000 tons in the first quarter due to mining commissioning challenges (compared to previous estimates of around 700,000 tons). When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Peabody Energy class action, go to https://rosenlegal.com/cases/peabody-energy-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com
2026-07-12 22:25 28d ago
2026-07-12 13:12 28d ago
SpaceX Has Officially Joined the Nasdaq-100. Here Are 3 Better Nasdaq-100 Stocks to Buy in July.
DASH DoorDash
FMP Stock News
Original source text
On July 7, Space Exploration Technologies (SPCX 4.51%) became one of the newest members of the Nasdaq-100, added just 15 trading days after its record-setting public debut under a new fast-entry rule. Roughly $800 billion sits in funds that track that index, so every one of them had to buy the stock, and that mechanical demand has grabbed a lot of headlines.

Here's the thing worth remembering: A stock may meet the criteria to be added to a prominent index, but that doesn't necessarily make it a good buy. Forced buying by passively managed funds can inflate the price of a freshly public, richly valued stock in the short term, but history is full of hyped-up index additions that later proved to be disappointing investments. Rather than chase the rocket, I'd point patient investors toward three quieter Nasdaq-100 members in the consumer world that are doing genuinely interesting things right now.

Today's Change

(

-4.51

%) $

-6.86

Current Price

$

145.30

1. Keurig Dr Pepper: A beverage giant reinventing itself Keurig Dr Pepper (KDP +3.09%) is in the middle of the boldest reinvention of its short life. It closed its roughly $18 billion acquisition of Dutch coffee company JDE Peet's this spring, and it plans to split itself into two focused, separately traded businesses by the end of 2026: a global coffee company and a North American refreshment-beverage company. The logic is that investors often value a focused business more highly than a sprawling one, so separating the two somewhat disparate units could bring value to the surface that's currently buried.

I'd weigh that against the debt the company took on to buy JDE Peet's, which meaningfully increased the combined company's leverage. That's the trade-off here: real transformation potential paired with a balance sheet that now has less room for error.

Today's Change

(

3.09

%) $

0.95

Current Price

$

31.67

2. O'Reilly Automotive: The compounder hiding in plain sight O'Reilly Automotive (ORLY +1.36%) sells auto parts, which sounds about as exciting as a Tuesday. But the company is the kind of steady grower that quietly builds wealth. When people keep older cars on the road longer, they need to buy more parts to fix them, which makes O'Reilly's business relatively resilient when household budgets tighten.

Image source: Getty Images.

The company performed a 15-for-1 stock split in 2025, lowering its per-share price so smaller investors can more easily buy whole shares or trade its options, and it keeps expanding, including a growing footprint in Mexico that now tops 120 stores.

Today's Change

(

1.36

%) $

1.16

Current Price

$

86.28

3. DoorDash: No longer just about dinner Most people still think of DoorDash (DASH 0.29%) as the app that brings burritos or burgers to their door. What I find more compelling is how far beyond restaurants it has pushed its operation. Its late-2025 acquisition of Deliveroo extended its reach across Europe, and it now claims some of the fastest growth among third-party players in U.S. grocery and retail. It's also building a genuine advertising business and testing autonomous delivery to lower costs over time.

The honest counterweight: DoorDash is spending heavily in 2026 to consolidate its technology and fund these bets, which will likely put more pressure on its near-term profits even after a record 2025. The stock isn't cheap relative to today's earnings, but those who pick it up now are buying for the long game.

Today's Change

(

-0.29

%) $

-0.56

Current Price

$

191.79

The takeaway for investors SpaceX's arrival in the Nasdaq-100 may be a milestone, but membership in the index only tells you a company is big, not that its stock is attractively priced. Keurig Dr Pepper, O'Reilly Automotive, and DoorDash each offer a few things that SpaceX doesn't right now: established businesses, track records you can actually examine, and clearer lines of sight on how they make money. None is a risk-free investment -- one carries debt, one carries a premium price, and one carries heavy spending -- but for July, I think these three warrant a closer look far more than the stock that everyone is talking about.

As for SpaceX itself, I'd wait. Let the initial hype fade and give the company a few quarters as a public business to prove out its numbers first.
2026-07-12 21:57 28d ago
2026-07-12 16:55 28d ago
Ultra Clean Insider Sells 3,837 Shares After Q1 Revenue Hit $533.7 Million
UCTT Ultra Clean Holdings
FMP Stock News
Original source text
Brian E. Harding, Chief Accounting Officer of Ultra Clean Holdings, Inc. (UCTT +0.07%), sold 3,837 shares of common stock at $128.75 per share on July 2, 2026, according to an SEC Form 4 filing.

Transaction summaryMetricValueShares sold (direct)3,837Transaction value~$494,000Post-transaction shares (directly held)33,581Post-transaction value$3.58 millionKey questionsWhat was the structural nature of this disposition?
The sale was systematic rather than discretionary, occurring via a Rule 10b5-1 plan adopted four months prior to execution to manage the insider's equity position.How does this impact the insider's total equity position?
Following the disposal, Harding maintains direct ownership of 33,581 shares.What is the financial context of the company at the time of the transaction?
Ultra Clean Holdings reported trailing twelve-month revenue of $2.1 billion and a net loss of $194.1 million, as the stock was priced at $105.53 as of the July 6, 2026 market close.What was the price context relative to the broader market close?
While shares were sold at a weighted average of $128.75, the stock closed at $106.48 on the transaction date, illustrating execution within the day's higher price bands.Company OverviewMetricValueShare Price (as of market close 2026-07-06)$105.53Market Capitalization$4.1 billionRevenue (TTM)$2.1 billionNet Income (TTM)-$194.1 millionCompany SnapshotUltra Clean Holdings provides essential subsystems, precision components, ultra-high purity cleaning services, and analytical verification solutions to the global semiconductor industry, with a comprehensive product portfolio including ultra-clean valves, high-purity connectors, pneumatic actuators, manifolds, and safety solutions.The company generates revenue through the design, manufacturing, and distribution of specialized semiconductor equipment and components, as well as through provision of critical cleaning and analytical services that support semiconductor fabrication and advanced manufacturing processes.Ultra Clean Holdings primarily serves semiconductor manufacturers and equipment suppliers globally, with a strong presence across the United States and international markets, positioning itself as a critical supplier to the semiconductor supply chain.Ultra Clean Holdings operates as a specialized supplier to the semiconductor industry with approximately 6,773 employees and a market capitalization of $4.1 billion. The company has demonstrated significant market momentum, with a one-year share price appreciation of 326.43%, reflecting strong investor confidence in its strategic positioning within the semiconductor equipment and services sector. Despite near-term profitability challenges reflected in a TTM net loss of $194.1 million, the company's substantial revenue base of $2.1 billion underscores its established market presence and critical role in supporting semiconductor manufacturing operations.

What this transaction means for investorsThe timing of this sale seems like some very well-timed housekeeping. Of course, as noted, Harding set the plan four months back, but he sold at $128.75 just as the stock began a steep slide, and within days shares had tumbled to the low $90s. Still, at roughly $494,000, this is still a small sale that leaves him with 33,581 shares worth around $3.5 million at recent prices, so this is a trim, not a retreat. Plus, he’s been selling consistently every month at around the same time. Worth noting is that other insiders, including the CFO, have also sold shares in recent weeks.

Meanwhile, the business is mid-turnaround. First-quarter revenue reached $533.7 million, and the company posted a non-GAAP profit of $0.31 a share even while absorbing a GAAP loss, with management leaning on its Vision 2030 targets and an AI-driven equipment cycle. For long-term investors, watch whether the AI spending wave holds, and whether insider selling stays a trickle or turns into a trend.

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-07-12 21:18 28d ago
2026-07-12 15:29 28d ago
If I Could Tell Every QQQ Investor 1 Thing About SpaceX's Nasdaq-100 Entry, It's This
SPCX SpaceX
FMP Stock News
Original source text
Space Exploration Technologies (SPCX 4.51%) joined the Nasdaq-100 index on July 7. If you own the Invesco QQQ ETF (QQQ +0.31%) or the Invesco Nasdaq 100 ETF (QQQM +0.32%), you now own a piece of it too.

SpaceX has gotten a lot of attention since its initial public offering (IPO). But now that it's getting added to major market indexes, the most important step is assessing its impact.

What might surprise many people is that, despite its massive $2 trillion market cap, the stock isn't nearly as influential in the Nasdaq-100 as you might think. And that's perhaps the biggest takeaway from this story.

Image source: Getty Images.

SpaceX isn't even a top-20 holding in the Nasdaq-100 The reason SpaceX has only a relatively minor influence on the index is the distinction between total market capitalization and free-float market capitalization.

Free-float market cap takes into account only the shares that are publicly available. For SpaceX, that's about 5% of the total shares available. Most companies only have a percentage of their total shares publicly tradable, but SpaceX has less than average.

By total market cap, SpaceX would rank as one of the 10 largest companies in the world. But because the Nasdaq-100 uses free-float market cap, it's only the 21st-largest holding in the index, between KLA and Texas Instruments. Its weight is 1.25%.

SpaceX won't have a meaningful impact on the Nasdaq-100 If you're buying either the Invesco QQQ ETF or the Invesco Nasdaq 100 ETF expecting a significant stake in SpaceX, you're probably going to be disappointed.

Even a major rally or crash in the stock market likely won't be felt in the index. The one thing to potentially be mindful of is the volatility of the stock. The IPO price was set at $135. It initially traded at around $150 when it went public, reached as high as $225, and is now back down to around $149.

There's a lot of noise in the trading behavior of this stock. From investors trying to get their hands on shares for the first time to the fund industry buying millions of shares to track their underlying indexes, volatility in SpaceX could be higher than average for a while until things settle a bit.

The next big milestone will be next summer when the stock becomes eligible for inclusion in the S&P 500 (^GSPC +0.42%). While there will be another wave of buying if and when that happens, expectations should be tempered on that day as well. The S&P 500 is also free-float, market-cap-weighted, and might receive an even smaller allocation there.

David Dierking has positions in Invesco NASDAQ 100 ETF. The Motley Fool has positions in and recommends KLA and Texas Instruments. The Motley Fool has a disclosure policy.
2026-07-12 21:18 28d ago
2026-07-12 16:20 28d ago
Prediction: SpaceX Shares Can Reach $220 by End of 2026
SPCX SpaceX
FMP Stock News
Original source text
Space Exploration Technologies (SPCX 4.51%) has become one of the market's most closely watched stocks after its rapid entry into the Nasdaq-100 index on July 7. Shares are trading close to $149 (as of July 10), still above its $135 IPO price, but nearly 34% below its post-IPO high of $225.60.

This share price pullback has not ended investor interest in SpaceX, but it has changed the debate. Investors are now weighing the company's artificial intelligence (AI) compute opportunity, Starlink satellite internet network's room to expand in satellite communications, and progress on the next-generation reusable rocket system, Starship, as they assess where the stock could trade by the end of 2026.

Image source: Getty Images.

SpaceX has growth drivers for its revenue SpaceX is already demonstrating impressive financial momentum. Revenue rose 33% year over year to $18.7 billion in 2025. But the company still reported a net loss of $4.9 billion after merging with money-losing xAI.

Starlink remains the key growth engine, supported by roughly 10.3 million users and 9,600 satellites. But AI infrastructure is also becoming the next major catalyst. Alphabet has agreed to pay SpaceX $920 million per month from October 2026 through June 2029 for access to about 110,000 Nvidia GPUs and related computing resources. Anthropic has also signed a major compute-access deal with SpaceX, securing use of SpaceX's Colossus 1 data center. Reuters reported that SpaceX's two deals are worth about $26 billion annually if fully realized.

Although not all the AI revenue from these deals is expected to materialize in 2026, it still gives investors a reason to value SpaceX based on future revenue potential rather than solely on 2025 sales.

Today's Change

(

-4.51

%) $

-6.86

Current Price

$

145.30

SpaceX's valuation will fall, but remain expensive At the end of 2026, investors will likely be looking toward SpaceX's expected 2027 revenue, since the stock's valuation depends on how quickly Starlink, AI compute, and Starship can expand the company's sales base.

SpaceX's market capitalization is close to $2 trillion. Analysts' 2026 revenue estimates range from $34.3 billion on the low end to $43.2 billion on the high end, with a base case estimate of about $38.9 billion. Hence, SpaceX is already trading at roughly 51.4 times base case 2026 sales. By the end of 2026, that multiple will most likely compress, as post-IPO excitement usually cools and investors demand evidence of execution. But it also does not need to collapse if SpaceX continues to show progress in Starlink, AI infrastructure, and Starship.

A reasonable base-case assumption is that SpaceX's sales multiple compresses by about 20% to 25% from today's 51.4x 2026 sales multiple. That gives a forward price-to-sales (P/S) multiple range of roughly 38.5 to 41 times expected 2027 sales.

Analysts expect SpaceX's 2027 revenue to range from $54.8 billion to $85 billion, with an average estimate of $72.4 billion. Applying a forward sales multiple of 38.5 to 41 times to the 2027 base case revenue estimate yields an implied market capitalization of about $2.79 trillion to $2.97 trillion. Using roughly 13.1 billion shares outstanding, that points to a share price in the range of $213 to $227 at the end of 2026.

Hence, $220 is a reasonable base case estimate. It assumes that while SpaceX's valuation multiple compresses, revenue growth offsets the pressure enough to lift the share price.
2026-07-12 21:17 28d ago
2026-07-12 16:30 28d ago
J.P. Morgan Called a Potential Elon Musk SpaceX-Tesla Merger "Strategically Coherent"
TSLA Tesla
FMP Stock News
Original source text
Now that Elon Musk's rocket and satellite company Space Exploration Technologies (SPCX 4.51%) trades publicly, Wall Street has started hunting for the next best thing: stocks that can ride its coattails. The most eye-catching call came from J.P. Morgan, whose analysts described a possible combination of SpaceX and Tesla (TSLA +0.22%) as "strategically coherent on paper." That single phrase has revived a long-running fantasy among investors, and it's worth understanding what the analyst company actually means before treating any of these names as a back door into SpaceX.

Today's Change

(

-4.51

%) $

-6.86

Current Price

$

145.30

Why J.P. Morgan sees logic in a Tesla-SpaceX tie-up J.P. Morgan's argument is that Musk's companies already share engineering talent, an artificial intelligence ambition, and a common leader, so uniting them could let him run one integrated vision across cars, robots, energy, and space. The analysts also noted that SpaceX's blockbuster public debut gives Musk valuable stock to make a deal, and that his growing voting control at Tesla makes him better positioned to push one through.

Image source: Getty Images.

J.P. Morgan was careful, though, and so am I. It flagged real obstacles: securing regulatory approvals across many countries, especially China, where Tesla builds cars; the awkward gap between Musk's near-total control of SpaceX and his smaller stake in Tesla; and the likelihood that any deal would look like SpaceX swallowing Tesla rather than a merger of equals.

"Coherent on paper" is a long way from "likely to happen."

Today's Change

(

0.22

%) $

0.90

Current Price

$

407.45

The other SpaceX-by-association plays Tesla isn't the only name catching the halo. Deutsche Bank started coverage of EchoStar (ECHO 2.00%) with a buy rating, framing it as a cheaper way to own SpaceX. EchoStar holds roughly $11 billion of SpaceX shares it received for handing over wireless spectrum, so the bank argues you're effectively buying SpaceX at a discount and getting EchoStar's other assets thrown in. The catch is serious: EchoStar's pay-TV subsidiary recently filed for bankruptcy, and the stock has tumbled.

Today's Change

(

-2.00

%) $

-1.96

Current Price

$

96.00

Then there's Charter Communications (CHTR 2.64%), which, according to Bloomberg, has held talks with SpaceX about a consumer mobile phone service that would route some traffic through Charter's network. It's a genuine strategic fit, but it's only talk for now.

Here's my honest read. Buying a stock because it's linked to a hot company is a strategy built on hope, not fundamentals, and all three of these names are down this year for reasons of their own. A merger that's merely "coherent on paper," a spectrum stake wrapped around a bankruptcy, and a rumored partnership are not the same as durable businesses. If you like Tesla, EchoStar, or Charter, buy them for what they do today, and treat any SpaceX connection as a bonus rather than the thesis.
2026-07-12 21:17 28d ago
2026-07-12 16:04 28d ago
Amazon Just Announced Shocking $25 Billion News. Should Investors Worry?
AMZN Amazon
FMP Stock News
Original source text
Amazon (AMZN 0.69%) is reported to have made a shocking decision in recent days. According to CNBC, it is issuing $25 billion in debt to fund its data center build-out. While it doesn't plan to issue any more debt beyond that in 2026, it's a big deal because Amazon's long-term debt has been soaring in the past few years.

Building data centers isn't cheap, and the cash has to come from somewhere, but is this the right move, or should it scare investors?

Image source: Getty Images.

The payoff could be immense In recent years, Amazon's debt load has skyrocketed from the company's historical levels.

AMZN Total Long Term Debt (Quarterly), data by YCharts.

The latest $25 billion sale of debt adds to this total, but Amazon has the cash flow to fund the repayment. The reality is that it's vital for the company to grab as much cloud infrastructure market share as possible in these early days of the AI build-out; it will be more difficult to win clients away from other cloud providers once everyone has their preferred vendor.

The company is currently leading the way among AI hyperscalers in data center construction plans, and it expects to lay out around $200 billion in capital expenditures this year. Over the past 12 months, Amazon generated just shy of $150 billion in cash from operations, so the gap between funds coming in and cash flowing out had to be closed somehow.

AMZN Cash from Operations (TTM), data by YCharts; TTM = trailing 12 months.

As a result, investors should not feel too blindsided by this debt issuance. But is it worth it?

CEO Andy Jassy said in his shareholder letter that the nature of a cloud computing business requires increased capital input when it's growing rapidly. Data centers aren't cheap to bring online, but they do have great payoffs over long time frames. Jassy also mentioned that a significant amount of the new computing capacity that $200 billion will buy is already under contract to customers, so it isn't just taking a leap of faith when building these data centers.

Once the construction is over and the company is benefiting from a much larger cloud computing footprint, its gains in revenue and cash flow will be immense, and should dwarf any concerns about its rising debt load. Current market conditions and demands dictate that management build more data centers, and that's exactly what it's doing.

With Amazon Web Services being a major part of the cloud computing landscape and an important part of the company's overall business, now is a perfect time to buy the stock, as Amazon's growth over the next few years could be immense.
2026-07-12 21:16 28d ago
2026-07-12 16:00 28d ago
Setting Stage for Mag 7 Earnings After 2Q Sets High Bar
MSFT Microsoft
FMP Stock News
Original source text
Jed Ellerbroek discusses the market's digestion of strong second-quarter gains, the impact of U.S.-Iran tensions on oil prices, and what's ahead for cyclical stocks. He highlights upcoming earnings from Alphabet (GOOGL), Amazon (AMZN), Meta Platforms (META) and Microsoft (MSFT).
2026-07-12 21:15 28d ago
2026-07-12 14:44 28d ago
Can Nvidia Still Turn Long-Term Investors Into Millionaires?
NVDA Nvidia
FMP Stock News
Original source text
Many early Nvidia (NVDA +3.90%) investors have become millionaires. While new investors definitely wish they had bought shares earlier, the stock is still trending higher. It's up by 25% over the past year.

While this stock isn't going to double or triple in a single year again, it's still outpacing most growth stocks. Combine that with fundamental business growth that is outpacing those stock gains, and it's still possible for Nvidia to turn new investors into millionaires.

Image source: Getty Images.

AI chip demand is still surging Nvidia became a household name because of its AI chips, and sales of those semiconductors have not shown any signs of slowing down. High demand from tech giants has helped Nvidia command high profit margins and deliver record revenues.

Today's Change

(

3.90

%) $

7.90

Current Price

$

210.68

The company's fiscal 2027 first-quarter results encapsulate the ongoing demand picture. Revenue rose by 85% year over year to $81.6 billion. Guidance for its fiscal 2027 second-quarter is for $91 billion in revenue, which would be more than 10% sequential growth.

Net income more than doubled in the period as well, resulting in a net profit margin above 70%. It's difficult for any company to deliver those types of numbers; Nvidia shareholders have gotten used to them.

The rising use of agentic AI and physical AI will only boost the demand for Nvidia's GPUs. The chipmaker even hired an orbital data center system architect, showing that it's priming itself to supply chips to companies that have ambitions to deploy cloud servers on orbiting satellites. Between its strong positioning for the present moment and its investments to capture future opportunities, Nvidia is set up to provide solid returns to long-term investors, even those who have only recently started to accumulate shares.

Nvidia's valuation is cheap Valuation can make or break a stock thesis. A low P/E ratio can make a decent company look like a compelling buy, while mounting losses and a high price-to-sales ratio can make a promising company a bad investment.

Nvidia has growth rates and a long-term trajectory that any company would love to have. However, it also trades at a surprisingly low P/E ratio of 30. For the sake of comparison, Walmart (WMT +1.48%) has a 39 P/E ratio, and it's not reporting growth rates or profits anywhere close to Nvidia's.

Even better, its fundamental growth has been outpacing its stock price gains. Nvidia's 85% year-over-year revenue growth in its fiscal 2027 first quarter was a mismatch to the 25% in stock gains over the past year. The gap between its net income growth and the stock price growth is even larger.

Some investors are looking to put money into smaller AI companies that they hope will deliver the types of compound growth that Nvidia has over the past decade. However, Nvidia is still in a good position to reward new investors and turn some of them into millionaires.